UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31,~~June 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________to__________


Commission File Number	Exact Name of Registrant as Specified in its Charter, Principal Office Address and Telephone Number	State of Incorporation or Organization	I.R.S. Employer Identification No.
001-38646	Dow Inc.	Delaware	30-1128146
	2211 H.H. Dow Way, Midland, MI 48674
	(989) 636-1000
001-03433	The Dow Chemical Company	Delaware	38-1285128
	2211 H.H. Dow Way, Midland, MI 48674
	(989) 636-1000

Securities registered pursuant to Section 12(b) of the Act:


Registrant	Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Dow Inc.	Common Stock, par value $0.01 per share	DOW	New York Stock Exchange
The Dow Chemical Company	0.500% Notes due March 15, 2027	DOW/27	New York Stock Exchange
The Dow Chemical Company	1.125% Notes due March 15, 2032	DOW/32	New York Stock Exchange
The Dow Chemical Company	1.875% Notes due March 15, 2040	DOW/40	New York Stock Exchange
The Dow Chemical Company	4.625% Notes due October 1, 2044	DOW/44	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Dow Inc.

☑

Yes

☐

The Dow Chemical Company

☑

Yes

☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Dow Inc.

☑

Yes

☐

The Dow Chemical Company

☑

Yes

☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Dow Inc.

Large accelerated filer

☑

Accelerated
filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

The Dow Chemical Company

Large accelerated filer

☐

Accelerated
filer

☐

Non-accelerated filer

☑

Smaller reporting company

☐

Emerging growth company

☐

Table of Contents

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Dow Inc.

☐

The Dow Chemical Company

☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Dow Inc.

☐

Yes

☑

The Dow Chemical Company

☐

Yes

☑

Dow Inc. had ~~707,314,807~~703,074,557 shares of common stock, $0.01 par value, outstanding at ~~March 31,~~June 30, 2023. The Dow Chemical Company had 100 shares of common stock, $0.01 par value, outstanding at ~~March 31,~~June 30, 2023, all of which were held by the registrant’s parent, Dow Inc.

The Dow Chemical Company meets the conditions set forth in General Instruction H(1)(a) and (b) for Form 10-Q and therefore is filing this form with a reduced disclosure format.

Table of Contents

Dow Inc. and Subsidiaries

The Dow Chemical Company and Subsidiaries

QUARTERLY REPORT ON FORM 10-Q

For the quarterly period ended ~~March 31,~~June 30, 2023

TABLE OF CONTENTS


		PAGE

PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements.	5
	Dow Inc. and Subsidiaries:
	Consolidated Statements of Income.	5
	Consolidated Statements of Comprehensive Income.	6
	Consolidated Balance Sheets.	7
	Consolidated Statements of Cash Flows.	8
	Consolidated Statements of Equity.	9

	The Dow Chemical Company and Subsidiaries:
	Consolidated Statements of Income.	10
	Consolidated Statements of Comprehensive Income.	11
	Consolidated Balance Sheets.	12
	Consolidated Statements of Cash Flows.	13
	Consolidated Statements of Equity.	14

	Dow Inc. and Subsidiaries and The Dow Chemical Company and Subsidiaries:
	Notes to the Consolidated Financial Statements.	15

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	33

	Results of Operations.	3534

	Changes in Financial Condition.	3940

	Other Matters.	45

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	46

Item 4.	Controls and Procedures.	46

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings.	47

Item 1A.	Risk Factors.	47

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	47

Item 4.	Mine Safety Disclosures.	47

Item 5.	Other Information.	47

Item 6.	Exhibits.	48

SIGNATURE		49

Table of Contents


Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries

This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the "Company") due to the parent/subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company.

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

Certain statements in this report are “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow’s control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow’s products; Dow’s expenses, future revenues and profitability; ~~the continuing~~any global and regional economic impacts of ~~the coronavirus disease 2019 (“COVID-19”)~~a pandemic ~~and~~or other public health-related risks and events on Dow’s business; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between Russia and Ukraine; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe; size of the markets for Dow’s products and services and ability to compete in such markets; failure to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow’s products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow’s intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow’s significant customers and suppliers; changes in consumer preferences and demand; changes in laws and regulations, political conditions or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflict between Russia and Ukraine; weather events and natural disasters; disruptions in Dow’s information technology networks and systems; and risks related to Dow’s separation from DowDuPont Inc. such as Dow’s obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” contained in Part II, Item 1A of this Quarterly Report on Form 10-Q and in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow’s business. Dow Inc. and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

Table of Contents


PART I – FINANCIAL INFORMATION


ITEM 1. FINANCIAL STATEMENTS

Dow Inc. and Subsidiaries

Consolidated Statements of Income


		Three Months Ended				Three Months Ended				Six Months Ended
In millions, except per share amounts (Unaudited)	In millions, except per share amounts (Unaudited)	Mar 31, 2023		Mar 31, 2022			In millions, except per share amounts (Unaudited)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net sales	Net sales	$	11,851	$	15,264		Net sales	$	11,420	$	15,664	$	23,271	$	30,928
Cost of sales	Cost of sales	10,629		12,402			Cost of sales	9,875		12,899		20,504		25,301
Research and development expenses	Research and development expenses	214		218			Research and development expenses	205		217		419		435
Selling, general and administrative expenses	Selling, general and administrative expenses	428		498			Selling, general and administrative expenses	408		435		836		933
Amortization of intangibles	Amortization of intangibles	81		88			Amortization of intangibles	81		85		162		173
Restructuring and asset related charges - net	Restructuring and asset related charges - net	541		186			Restructuring and asset related charges - net	8		—		549		186
Equity in earnings (losses) of nonconsolidated affiliates	Equity in earnings (losses) of nonconsolidated affiliates	(48)		174			Equity in earnings (losses) of nonconsolidated affiliates	(57)		195		(105)		369
Sundry income (expense) - net	Sundry income (expense) - net	79		148			Sundry income (expense) - net	31		75		110		223
Interest income	Interest income	76		28			Interest income	66		36		142		64
Interest expense and amortization of debt discount	Interest expense and amortization of debt discount	185		167			Interest expense and amortization of debt discount	172		165		357		332
Income (loss) before income taxes		(120)		2,055
Provision (credit) for income taxes		(47)		503
Net income (loss)		(73)		1,552
Net income (loss) attributable to noncontrolling interests		20		(17)
Net income (loss) available for Dow Inc. common stockholders		$	(93)	$	1,569
Income before income taxes							Income before income taxes	711		2,169		591		4,224
Provision for income taxes							Provision for income taxes	210		488		163		991
Net income							Net income	501		1,681		428		3,233
Net income attributable to noncontrolling interests							Net income attributable to noncontrolling interests	16		20		36		3
Net income available for Dow Inc. common stockholders							Net income available for Dow Inc. common stockholders	$	485	$	1,661	$	392	$	3,230

Per common share data:	Per common share data:						Per common share data:
Earnings (loss) per common share - basic		$	(0.13)	$	2.12
Earnings (loss) per common share - diluted		$	(0.13)	$	2.11
Earnings per common share - basic							Earnings per common share - basic	$	0.68	$	2.28	$	0.55	$	4.40
Earnings per common share - diluted							Earnings per common share - diluted	$	0.68	$	2.26	$	0.54	$	4.37

Weighted-average common shares outstanding - basic	Weighted-average common shares outstanding - basic	708.2		734.6			Weighted-average common shares outstanding - basic	707.0		725.7		707.6		730.2
Weighted-average common shares outstanding - diluted	Weighted-average common shares outstanding - diluted	708.2		739.8			Weighted-average common shares outstanding - diluted	709.9		731.5		710.7		735.6

Depreciation	Depreciation	$	475	$	491		Depreciation	$	484	$	486	$	959	$	977
Capital expenditures	Capital expenditures	$	440	$	315		Capital expenditures	$	561	$	457	$	1,001	$	772

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income


		Three Months Ended				Three Months Ended				Six Months Ended
In millions (Unaudited)	In millions (Unaudited)	Mar 31, 2023		Mar 31, 2022			In millions (Unaudited)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net income (loss)		$	(73)	$	1,552
Net income							Net income	$	501	$	1,681	$	428	$	3,233
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax						Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	Unrealized gains (losses) on investments	31		(96)			Unrealized gains (losses) on investments	61		(153)		92		(249)
Cumulative translation adjustments	Cumulative translation adjustments	101		(164)			Cumulative translation adjustments	(103)		(514)		(2)		(678)
Pension and other postretirement benefit plans	Pension and other postretirement benefit plans	6		109			Pension and other postretirement benefit plans	(4)		122		2		231
Derivative instruments	Derivative instruments	(64)		332			Derivative instruments	44		137		(20)		469
Total other comprehensive income		74		181
Total other comprehensive income (loss)							Total other comprehensive income (loss)	(2)		(408)		72		(227)
Comprehensive income	Comprehensive income	1		1,733			Comprehensive income	499		1,273		500		3,006
Comprehensive income (loss) attributable to noncontrolling interests, net of tax		20		(17)
Comprehensive income (loss) attributable to Dow Inc.		$	(19)	$	1,750
Comprehensive income attributable to noncontrolling interests, net of tax							Comprehensive income attributable to noncontrolling interests, net of tax	16		20		36		3
Comprehensive income attributable to Dow Inc.							Comprehensive income attributable to Dow Inc.	$	483	$	1,253	$	464	$	3,003

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Balance Sheets


In millions, except share amounts (Unaudited)	In millions, except share amounts (Unaudited)	Mar 31, 2023		Dec 31, 2022		In millions, except share amounts (Unaudited)	Jun 30, 2023		Dec 31, 2022
Assets	Assets					Assets
Current Assets	Current Assets					Current Assets
Cash and cash equivalents	Cash and cash equivalents	$	3,319	$	3,886	Cash and cash equivalents	$	2,924	$	3,886
Accounts and notes receivable:	Accounts and notes receivable:					Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2023: $110; 2022: $110)		5,740		5,611
Trade (net of allowance for doubtful receivables - 2023: $105; 2022: $110)						Trade (net of allowance for doubtful receivables - 2023: $105; 2022: $110)	5,539		5,611
Other	Other	2,072		2,144		Other	2,119		2,144
Inventories	Inventories	6,825		6,988		Inventories	6,487		6,988
Other current assets	Other current assets	1,400		1,848		Other current assets	1,480		1,848
Total current assets	Total current assets	19,356		20,477		Total current assets	18,549		20,477
Investments	Investments					Investments
Investment in nonconsolidated affiliates	Investment in nonconsolidated affiliates	1,508		1,589		Investment in nonconsolidated affiliates	1,335		1,589
Other investments (investments carried at fair value - 2023: $1,806; 2022: $1,757)		2,815		2,793
Other investments (investments carried at fair value - 2023: $1,802; 2022: $1,757)						Other investments (investments carried at fair value - 2023: $1,802; 2022: $1,757)	2,823		2,793
Noncurrent receivables	Noncurrent receivables	627		666		Noncurrent receivables	561		666
Total investments	Total investments	4,950		5,048		Total investments	4,719		5,048
Property	Property					Property
Property	Property	58,679		58,055		Property	59,145		58,055
Less: Accumulated depreciation	Less: Accumulated depreciation	38,356		37,613		Less: Accumulated depreciation	38,743		37,613
Net property	Net property	20,323		20,442		Net property	20,402		20,442
Other Assets	Other Assets					Other Assets
Goodwill	Goodwill	8,653		8,644		Goodwill	8,615		8,644
Other intangible assets (net of accumulated amortization - 2023: $5,114; 2022: $5,022)		2,336		2,442
Other intangible assets (net of accumulated amortization - 2023: $5,201; 2022: $5,022)						Other intangible assets (net of accumulated amortization - 2023: $5,201; 2022: $5,022)	2,231		2,442
Operating lease right-of-use assets	Operating lease right-of-use assets	1,257		1,227		Operating lease right-of-use assets	1,297		1,227
Deferred income tax assets	Deferred income tax assets	995		960		Deferred income tax assets	1,075		960
Deferred charges and other assets	Deferred charges and other assets	1,446		1,363		Deferred charges and other assets	1,406		1,363
Total other assets	Total other assets	14,687		14,636		Total other assets	14,624		14,636
Total Assets	Total Assets	$	59,316	$	60,603	Total Assets	$	58,294	$	60,603
Liabilities and Equity	Liabilities and Equity					Liabilities and Equity
Current Liabilities	Current Liabilities					Current Liabilities
Notes payable	Notes payable	$	278	$	362	Notes payable	$	102	$	362
Long-term debt due within one year	Long-term debt due within one year	247		362		Long-term debt due within one year	107		362
Accounts payable:	Accounts payable:					Accounts payable:
Trade	Trade	4,575		4,940		Trade	4,286		4,940
Other	Other	1,985		2,276		Other	1,879		2,276
Operating lease liabilities - current	Operating lease liabilities - current	304		287		Operating lease liabilities - current	317		287
Income taxes payable	Income taxes payable	335		334		Income taxes payable	339		334
Accrued and other current liabilities	Accrued and other current liabilities	2,765		2,770		Accrued and other current liabilities	2,619		2,770
Total current liabilities	Total current liabilities	10,489		11,331		Total current liabilities	9,649		11,331
Long-Term Debt	Long-Term Debt	14,739		14,698		Long-Term Debt	14,735		14,698
Other Noncurrent Liabilities	Other Noncurrent Liabilities					Other Noncurrent Liabilities
Deferred income tax liabilities	Deferred income tax liabilities	744		1,110		Deferred income tax liabilities	671		1,110
Pension and other postretirement benefits - noncurrent	Pension and other postretirement benefits - noncurrent	3,799		3,808		Pension and other postretirement benefits - noncurrent	3,735		3,808
Asbestos-related liabilities - noncurrent	Asbestos-related liabilities - noncurrent	844		857		Asbestos-related liabilities - noncurrent	819		857
Operating lease liabilities - noncurrent	Operating lease liabilities - noncurrent	1,007		997		Operating lease liabilities - noncurrent	1,036		997
Other noncurrent obligations	Other noncurrent obligations	6,979		6,555		Other noncurrent obligations	7,140		6,555
Total other noncurrent liabilities	Total other noncurrent liabilities	13,373		13,327		Total other noncurrent liabilities	13,401		13,327
Stockholders’ Equity	Stockholders’ Equity					Stockholders’ Equity
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2023: 775,463,877 shares; 2022: 771,678,525 shares)		8		8
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2023: 775,474,359 shares; 2022: 771,678,525 shares)						Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2023: 775,474,359 shares; 2022: 771,678,525 shares)	8		8
Additional paid-in capital	Additional paid-in capital	8,607		8,540		Additional paid-in capital	8,661		8,540
Retained earnings	Retained earnings	22,584		23,180		Retained earnings	22,570		23,180
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(7,065)		(7,139)		Accumulated other comprehensive loss	(7,067)		(7,139)
Treasury stock at cost (2023: 68,149,070 shares; 2022: 66,798,605 shares)		(3,953)		(3,871)
Treasury stock at cost (2023: 72,399,802 shares; 2022: 66,798,605 shares)						Treasury stock at cost (2023: 72,399,802 shares; 2022: 66,798,605 shares)	(4,175)		(3,871)
Dow Inc.’s stockholders’ equity	Dow Inc.’s stockholders’ equity	20,181		20,718		Dow Inc.’s stockholders’ equity	19,997		20,718
Noncontrolling interests	Noncontrolling interests	534		529		Noncontrolling interests	512		529
Total equity	Total equity	20,715		21,247		Total equity	20,509		21,247
Total Liabilities and Equity	Total Liabilities and Equity	$	59,316	$	60,603	Total Liabilities and Equity	$	58,294	$	60,603

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Cash Flows


In millions (Unaudited)	In millions (Unaudited)	Three Months Ended				In millions (Unaudited)	Six Months Ended
		Mar 31, 2023		Mar 31, 2022			Jun 30, 2023		Jun 30, 2022
Operating Activities	Operating Activities					Operating Activities
Net income (loss)		$	(73)	$	1,552
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net income						Net income	$	428	$	3,233
Adjustments to reconcile net income to net cash provided by operating activities:						Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	Depreciation and amortization	648		752		Depreciation and amortization	1,297		1,436
Provision (credit) for deferred income tax	Provision (credit) for deferred income tax	(418)		253		Provision (credit) for deferred income tax	(589)		348
Earnings of nonconsolidated affiliates less than dividends received	Earnings of nonconsolidated affiliates less than dividends received	102		374		Earnings of nonconsolidated affiliates less than dividends received	267		289
Net periodic pension benefit cost (credit)	Net periodic pension benefit cost (credit)	(23)		7		Net periodic pension benefit cost (credit)	(46)		14
Pension contributions	Pension contributions	(41)		(55)		Pension contributions	(76)		(89)
Net gain on sales of assets, businesses and investments		(49)		(6)
Net (gain) loss on sales of assets, businesses and investments						Net (gain) loss on sales of assets, businesses and investments	(51)		6

Restructuring and asset related charges - net	Restructuring and asset related charges - net	541		186		Restructuring and asset related charges - net	549		186
Other net loss	Other net loss	347		140		Other net loss	492		92
Changes in assets and liabilities, net of effects of acquired and divested companies:	Changes in assets and liabilities, net of effects of acquired and divested companies:					Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable	Accounts and notes receivable	(68)		(741)		Accounts and notes receivable	156		(767)
Inventories	Inventories	163		(443)		Inventories	501		(908)
Accounts payable	Accounts payable	(631)		86		Accounts payable	(986)		69
Other assets and liabilities, net	Other assets and liabilities, net	33		(493)		Other assets and liabilities, net	(64)		(441)
Cash provided by operating activities - continuing operations	Cash provided by operating activities - continuing operations	531		1,612		Cash provided by operating activities - continuing operations	1,878		3,468
Cash provided by (used for) operating activities - discontinued operations	Cash provided by (used for) operating activities - discontinued operations	4		(9)		Cash provided by (used for) operating activities - discontinued operations	4		(11)
Cash provided by operating activities	Cash provided by operating activities	535		1,603		Cash provided by operating activities	1,882		3,457
Investing Activities	Investing Activities					Investing Activities
Capital expenditures	Capital expenditures	(440)		(315)		Capital expenditures	(1,001)		(772)
Investment in gas field developments	Investment in gas field developments	(55)		(37)		Investment in gas field developments	(124)		(80)
Purchases of previously leased assets	Purchases of previously leased assets	(2)		(2)		Purchases of previously leased assets	(3)		(3)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested	Proceeds from sales of property, businesses and consolidated companies, net of cash divested	57		4		Proceeds from sales of property, businesses and consolidated companies, net of cash divested	59		5
Acquisitions of property and businesses, net of cash acquired	Acquisitions of property and businesses, net of cash acquired	(23)		—		Acquisitions of property and businesses, net of cash acquired	(54)		—
Investments in and loans to nonconsolidated affiliates	Investments in and loans to nonconsolidated affiliates	—		(6)		Investments in and loans to nonconsolidated affiliates	(2)		(33)
Distributions and loan repayments from nonconsolidated affiliates	Distributions and loan repayments from nonconsolidated affiliates	1		—		Distributions and loan repayments from nonconsolidated affiliates	1		10
Proceeds from sales of ownership interests in nonconsolidated affiliates	Proceeds from sales of ownership interests in nonconsolidated affiliates	—		11		Proceeds from sales of ownership interests in nonconsolidated affiliates	63		11
Purchases of investments	Purchases of investments	(165)		(148)		Purchases of investments	(821)		(278)
Proceeds from sales and maturities of investments	Proceeds from sales and maturities of investments	512		141		Proceeds from sales and maturities of investments	1,083		418

Other investing activities, net	Other investing activities, net	(35)		(15)		Other investing activities, net	(35)		(41)
Cash used for investing activities	Cash used for investing activities	(150)		(367)		Cash used for investing activities	(834)		(763)
Financing Activities	Financing Activities					Financing Activities
Changes in short-term notes payable	Changes in short-term notes payable	(91)		(21)		Changes in short-term notes payable	(255)		180

Payments on short-term debt greater than three months	Payments on short-term debt greater than three months	—		(14)		Payments on short-term debt greater than three months	—		(14)
Proceeds from issuance of long-term debt	Proceeds from issuance of long-term debt	13		16		Proceeds from issuance of long-term debt	55		49
Payments on long-term debt	Payments on long-term debt	(156)		(25)		Payments on long-term debt	(320)		(927)
Collections on securitization programs		—		141

Purchases of treasury stock	Purchases of treasury stock	(125)		(600)		Purchases of treasury stock	(375)		(1,400)
Proceeds from issuance of stock	Proceeds from issuance of stock	55		35		Proceeds from issuance of stock	55		97

Transaction financing, debt issuance and other costs						Transaction financing, debt issuance and other costs	(1)		(7)
Employee taxes paid for share-based payment arrangements	Employee taxes paid for share-based payment arrangements	(41)		(35)		Employee taxes paid for share-based payment arrangements	(41)		(34)
Distributions to noncontrolling interests	Distributions to noncontrolling interests	(13)		(1)		Distributions to noncontrolling interests	(36)		(22)

Dividends paid to stockholders	Dividends paid to stockholders	(496)		(513)		Dividends paid to stockholders	(989)		(1,018)

Cash used for financing activities	Cash used for financing activities	(854)		(1,017)		Cash used for financing activities	(1,907)		(3,096)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(41)		(45)		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(98)		(162)

Summary	Summary					Summary
Increase (decrease) in cash, cash equivalents and restricted cash		(510)		174
Decrease in cash, cash equivalents and restricted cash						Decrease in cash, cash equivalents and restricted cash	(957)		(564)
Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	3,940		3,033		Cash, cash equivalents and restricted cash at beginning of period	3,940		3,033
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	3,430	$	3,207	Cash, cash equivalents and restricted cash at end of period	$	2,983	$	2,469
Less: Restricted cash and cash equivalents, included in "Other current assets"	Less: Restricted cash and cash equivalents, included in "Other current assets"	111		64		Less: Restricted cash and cash equivalents, included in "Other current assets"	59		102
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	3,319	$	3,143	Cash and cash equivalents at end of period	$	2,924	$	2,367

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Equity


		Three Months Ended				Three Months Ended				Six Months Ended
In millions, except per share amounts (Unaudited)	In millions, except per share amounts (Unaudited)	Mar 31, 2023		Mar 31, 2022			In millions, except per share amounts (Unaudited)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Common Stock	Common Stock						Common Stock
Balance at beginning and end of period	Balance at beginning and end of period	$	8	$	8		Balance at beginning and end of period	$	8	$	8	$	8	$	8

Additional Paid-in Capital	Additional Paid-in Capital						Additional Paid-in Capital
Balance at beginning of period	Balance at beginning of period	8,540		8,151			Balance at beginning of period	8,607		8,217		8,540		8,151
Common stock issued/sold	Common stock issued/sold	55		35			Common stock issued/sold	—		62		55		97
Stock-based compensation and allocation of ESOP shares	Stock-based compensation and allocation of ESOP shares	56		35			Stock-based compensation and allocation of ESOP shares	84		84		140		119
Treasury stock issuances - compensation and benefit plans	Treasury stock issuances - compensation and benefit plans	(44)		(4)			Treasury stock issuances - compensation and benefit plans	(30)		(20)		(74)		(24)

Balance at end of period	Balance at end of period	8,607		8,217			Balance at end of period	8,661		8,343		8,661		8,343
Retained Earnings	Retained Earnings						Retained Earnings
Balance at beginning of period	Balance at beginning of period	23,180		20,623			Balance at beginning of period	22,584		21,672		23,180		20,623
Net income (loss) available for Dow Inc. common stockholders		(93)		1,569
Net income available for Dow Inc. common stockholders							Net income available for Dow Inc. common stockholders	485		1,661		392		3,230
Dividends to stockholders	Dividends to stockholders	(496)		(513)			Dividends to stockholders	(493)		(505)		(989)		(1,018)

Other	Other	(7)		(7)			Other	(6)		(1)		(13)		(8)
Balance at end of period	Balance at end of period	22,584		21,672			Balance at end of period	22,570		22,827		22,570		22,827
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss						Accumulated Other Comprehensive Loss
Balance at beginning of period	Balance at beginning of period	(7,139)		(8,977)			Balance at beginning of period	(7,065)		(8,796)		(7,139)		(8,977)
Other comprehensive income		74		181
Other comprehensive income (loss)							Other comprehensive income (loss)	(2)		(408)		72		(227)

Balance at end of period	Balance at end of period	(7,065)		(8,796)			Balance at end of period	(7,067)		(9,204)		(7,067)		(9,204)
Unearned ESOP Shares	Unearned ESOP Shares						Unearned ESOP Shares
Balance at beginning of period	Balance at beginning of period	—		(15)			Balance at beginning of period	—		—		—		(15)

Allocation of ESOP shares	Allocation of ESOP shares	—		15			Allocation of ESOP shares	—		—		—		15
Balance at end of period	Balance at end of period	—		—			Balance at end of period	—		—		—		—
Treasury Stock	Treasury Stock						Treasury Stock
Balance at beginning of period	Balance at beginning of period	(3,871)		(1,625)			Balance at beginning of period	(3,953)		(2,221)		(3,871)		(1,625)
Treasury stock purchases	Treasury stock purchases	(126)		(600)			Treasury stock purchases	(252)		(800)		(378)		(1,400)
Treasury stock issuances - compensation and benefit plans	Treasury stock issuances - compensation and benefit plans	44		4			Treasury stock issuances - compensation and benefit plans	30		20		74		24
Balance at end of period	Balance at end of period	(3,953)		(2,221)			Balance at end of period	(4,175)		(3,001)		(4,175)		(3,001)
Dow Inc.'s stockholders' equity	Dow Inc.'s stockholders' equity	20,181		18,880			Dow Inc.'s stockholders' equity	19,997		18,973		19,997		18,973
Noncontrolling Interests	Noncontrolling Interests	534		545			Noncontrolling Interests	512		534		512		534
Total Equity	Total Equity	$	20,715	$	19,425		Total Equity	$	20,509	$	19,507	$	20,509	$	19,507

Dividends declared per share of common stock	Dividends declared per share of common stock	$	0.70	$	0.70		Dividends declared per share of common stock	$	0.70	$	0.70	$	1.40	$	1.40

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Income


		Three Months Ended				Three Months Ended				Six Months Ended
In millions (Unaudited)	In millions (Unaudited)	Mar 31, 2023		Mar 31, 2022			In millions (Unaudited)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net sales	Net sales	$	11,851	$	15,264		Net sales	$	11,420	$	15,664	$	23,271	$	30,928
Cost of sales	Cost of sales	10,628		12,398			Cost of sales	9,874		12,899		20,502		25,297
Research and development expenses	Research and development expenses	214		218			Research and development expenses	205		217		419		435
Selling, general and administrative expenses	Selling, general and administrative expenses	428		498			Selling, general and administrative expenses	408		434		836		932
Amortization of intangibles	Amortization of intangibles	81		88			Amortization of intangibles	81		85		162		173
Restructuring and asset related charges - net	Restructuring and asset related charges - net	541		186			Restructuring and asset related charges - net	8		—		549		186
Equity in earnings (losses) of nonconsolidated affiliates	Equity in earnings (losses) of nonconsolidated affiliates	(48)		174			Equity in earnings (losses) of nonconsolidated affiliates	(57)		195		(105)		369
Sundry income (expense) - net	Sundry income (expense) - net	69		136			Sundry income (expense) - net	29		78		98		214
Interest income	Interest income	78		28			Interest income	69		38		147		66
Interest expense and amortization of debt discount	Interest expense and amortization of debt discount	185		167			Interest expense and amortization of debt discount	172		165		357		332
Income (loss) before income taxes		(127)		2,047
Provision (credit) for income taxes		(47)		503
Net income (loss)		(80)		1,544
Net income (loss) attributable to noncontrolling interests		20		(17)
Net income (loss) available for The Dow Chemical Company common stockholder		$	(100)	$	1,561
Income before income taxes							Income before income taxes	713		2,175		586		4,222
Provision for income taxes							Provision for income taxes	210		488		163		991
Net income							Net income	503		1,687		423		3,231
Net income attributable to noncontrolling interests							Net income attributable to noncontrolling interests	16		20		36		3
Net income available for The Dow Chemical Company common stockholder							Net income available for The Dow Chemical Company common stockholder	$	487	$	1,667	$	387	$	3,228

Depreciation	Depreciation	$	475	$	491		Depreciation	$	484	$	486	$	959	$	977
Capital expenditures	Capital expenditures	$	440	$	315		Capital expenditures	$	561	$	457	$	1,001	$	772

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Comprehensive Income


		Three Months Ended				Three Months Ended				Six Months Ended
In millions (Unaudited)	In millions (Unaudited)	Mar 31, 2023		Mar 31, 2022			In millions (Unaudited)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net income (loss)		$	(80)	$	1,544
Net income							Net income	$	503	$	1,687	$	423	$	3,231
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax						Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	Unrealized gains (losses) on investments	31		(96)			Unrealized gains (losses) on investments	61		(153)		92		(249)
Cumulative translation adjustments	Cumulative translation adjustments	101		(164)			Cumulative translation adjustments	(103)		(514)		(2)		(678)
Pension and other postretirement benefit plans	Pension and other postretirement benefit plans	6		109			Pension and other postretirement benefit plans	(4)		122		2		231
Derivative instruments	Derivative instruments	(64)		332			Derivative instruments	44		137		(20)		469
Total other comprehensive income		74		181
Comprehensive income (loss)		(6)		1,725
Comprehensive income (loss) attributable to noncontrolling interests, net of tax		20		(17)
Comprehensive income (loss) attributable to The Dow Chemical Company		$	(26)	$	1,742
Total other comprehensive income (loss)							Total other comprehensive income (loss)	(2)		(408)		72		(227)
Comprehensive income							Comprehensive income	501		1,279		495		3,004
Comprehensive income attributable to noncontrolling interests, net of tax							Comprehensive income attributable to noncontrolling interests, net of tax	16		20		36		3
Comprehensive income attributable to The Dow Chemical Company							Comprehensive income attributable to The Dow Chemical Company	$	485	$	1,259	$	459	$	3,001

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Balance Sheets


In millions, except share amounts (Unaudited)	In millions, except share amounts (Unaudited)	Mar 31, 2023		Dec 31, 2022		In millions, except share amounts (Unaudited)	Jun 30, 2023		Dec 31, 2022
Assets	Assets					Assets
Current Assets	Current Assets					Current Assets
Cash and cash equivalents	Cash and cash equivalents	$	3,319	$	3,886	Cash and cash equivalents	$	2,924	$	3,886

Accounts and notes receivable:	Accounts and notes receivable:					Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2023: $110; 2022: $110)		5,740		5,611
Trade (net of allowance for doubtful receivables - 2023: $105; 2022: $110)						Trade (net of allowance for doubtful receivables - 2023: $105; 2022: $110)	5,539		5,611
Other	Other	2,069		2,211		Other	2,111		2,211
Inventories	Inventories	6,825		6,988		Inventories	6,487		6,988
Other current assets	Other current assets	1,377		1,815		Other current assets	1,451		1,815
Total current assets	Total current assets	19,330		20,511		Total current assets	18,512		20,511
Investments	Investments					Investments
Investment in nonconsolidated affiliates	Investment in nonconsolidated affiliates	1,508		1,589		Investment in nonconsolidated affiliates	1,335		1,589
Other investments (investments carried at fair value - 2023: $1,806; 2022: $1,757)		2,815		2,793
Other investments (investments carried at fair value - 2023: $1,802; 2022: $1,757)						Other investments (investments carried at fair value - 2023: $1,802; 2022: $1,757)	2,823		2,793
Noncurrent receivables	Noncurrent receivables	607		650		Noncurrent receivables	534		650
Total investments	Total investments	4,930		5,032		Total investments	4,692		5,032
Property	Property					Property
Property	Property	58,679		58,055		Property	59,145		58,055
Less accumulated depreciation	Less accumulated depreciation	38,356		37,613		Less accumulated depreciation	38,743		37,613
Net property	Net property	20,323		20,442		Net property	20,402		20,442
Other Assets	Other Assets					Other Assets
Goodwill	Goodwill	8,653		8,644		Goodwill	8,615		8,644
Other intangible assets (net of accumulated amortization - 2023: $5,114; 2022: $5,022)		2,336		2,442
Other intangible assets (net of accumulated amortization - 2023: $5,201; 2022: $5,022)						Other intangible assets (net of accumulated amortization - 2023: $5,201; 2022: $5,022)	2,231		2,442
Operating lease right-of-use assets	Operating lease right-of-use assets	1,257		1,227		Operating lease right-of-use assets	1,297		1,227
Deferred income tax assets	Deferred income tax assets	995		960		Deferred income tax assets	1,075		960
Deferred charges and other assets	Deferred charges and other assets	1,446		1,363		Deferred charges and other assets	1,406		1,363
Total other assets	Total other assets	14,687		14,636		Total other assets	14,624		14,636
Total Assets	Total Assets	$	59,270	$	60,621	Total Assets	$	58,230	$	60,621
Liabilities and Equity	Liabilities and Equity					Liabilities and Equity
Current Liabilities	Current Liabilities					Current Liabilities
Notes payable	Notes payable	$	278	$	362	Notes payable	$	102	$	362
Long-term debt due within one year	Long-term debt due within one year	247		362		Long-term debt due within one year	107		362
Accounts payable:	Accounts payable:					Accounts payable:
Trade	Trade	4,575		4,940		Trade	4,286		4,940
Other	Other	1,985		2,349		Other	1,879		2,349
Operating lease liabilities - current	Operating lease liabilities - current	304		287		Operating lease liabilities - current	317		287
Income taxes payable	Income taxes payable	335		334		Income taxes payable	339		334

Accrued and other current liabilities	Accrued and other current liabilities	2,623		2,613		Accrued and other current liabilities	2,472		2,613
Total current liabilities	Total current liabilities	10,347		11,247		Total current liabilities	9,502		11,247
Long-Term Debt	Long-Term Debt	14,739		14,698		Long-Term Debt	14,735		14,698
Other Noncurrent Liabilities	Other Noncurrent Liabilities					Other Noncurrent Liabilities
Deferred income tax liabilities	Deferred income tax liabilities	744		1,110		Deferred income tax liabilities	671		1,110
Pension and other postretirement benefits - noncurrent	Pension and other postretirement benefits - noncurrent	3,799		3,808		Pension and other postretirement benefits - noncurrent	3,735		3,808
Asbestos-related liabilities - noncurrent	Asbestos-related liabilities - noncurrent	844		857		Asbestos-related liabilities - noncurrent	819		857
Operating lease liabilities - noncurrent	Operating lease liabilities - noncurrent	1,007		997		Operating lease liabilities - noncurrent	1,036		997
Other noncurrent obligations	Other noncurrent obligations	6,837		6,415		Other noncurrent obligations	6,996		6,415
Total other noncurrent liabilities	Total other noncurrent liabilities	13,231		13,187		Total other noncurrent liabilities	13,257		13,187
Stockholder's Equity	Stockholder's Equity					Stockholder's Equity
Common stock (authorized and issued 100 shares of $0.01 par value each)	Common stock (authorized and issued 100 shares of $0.01 par value each)	—		—		Common stock (authorized and issued 100 shares of $0.01 par value each)	—		—
Additional paid-in capital	Additional paid-in capital	8,738		8,627		Additional paid-in capital	8,822		8,627
Retained earnings	Retained earnings	18,746		19,472		Retained earnings	18,469		19,472
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(7,065)		(7,139)		Accumulated other comprehensive loss	(7,067)		(7,139)

The Dow Chemical Company’s stockholder's equity	The Dow Chemical Company’s stockholder's equity	20,419		20,960		The Dow Chemical Company’s stockholder's equity	20,224		20,960
Noncontrolling interests	Noncontrolling interests	534		529		Noncontrolling interests	512		529
Total equity	Total equity	20,953		21,489		Total equity	20,736		21,489
Total Liabilities and Equity	Total Liabilities and Equity	$	59,270	$	60,621	Total Liabilities and Equity	$	58,230	$	60,621

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Cash Flows


In millions (Unaudited)	In millions (Unaudited)	Three Months Ended				In millions (Unaudited)	Six Months Ended
		Mar 31, 2023		Mar 31, 2022			Jun 30, 2023		Jun 30, 2022
Operating Activities	Operating Activities					Operating Activities
Net income (loss)		$	(80)	$	1,544
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net income						Net income	$	423	$	3,231
Adjustments to reconcile net income to net cash provided by operating activities:						Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	Depreciation and amortization	648		752		Depreciation and amortization	1,297		1,436
Provision (credit) for deferred income tax	Provision (credit) for deferred income tax	(418)		253		Provision (credit) for deferred income tax	(589)		348
Earnings of nonconsolidated affiliates less than dividends received	Earnings of nonconsolidated affiliates less than dividends received	102		374		Earnings of nonconsolidated affiliates less than dividends received	267		289
Net periodic pension benefit cost (credit)	Net periodic pension benefit cost (credit)	(23)		7		Net periodic pension benefit cost (credit)	(46)		14
Pension contributions	Pension contributions	(41)		(55)		Pension contributions	(76)		(89)
Net gain on sales of assets, businesses and investments		(49)		(6)
Net (gain) loss on sales of assets, businesses and investments						Net (gain) loss on sales of assets, businesses and investments	(51)		6
Restructuring and asset related charges - net	Restructuring and asset related charges - net	541		186		Restructuring and asset related charges - net	549		186
Other net loss	Other net loss	348		140		Other net loss	493		97
Changes in assets and liabilities, net of effects of acquired and divested companies:	Changes in assets and liabilities, net of effects of acquired and divested companies:					Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable	Accounts and notes receivable	(68)		(741)		Accounts and notes receivable	156		(767)
Inventories	Inventories	163		(443)		Inventories	501		(908)
Accounts payable	Accounts payable	(631)		86		Accounts payable	(986)		69
Other assets and liabilities, net	Other assets and liabilities, net	42		(486)		Other assets and liabilities, net	(42)		(419)
Cash provided by operating activities	Cash provided by operating activities	534		1,611		Cash provided by operating activities	1,896		3,493
Investing Activities	Investing Activities					Investing Activities
Capital expenditures	Capital expenditures	(440)		(315)		Capital expenditures	(1,001)		(772)
Investment in gas field developments	Investment in gas field developments	(55)		(37)		Investment in gas field developments	(124)		(80)
Purchases of previously leased assets	Purchases of previously leased assets	(2)		(2)		Purchases of previously leased assets	(3)		(3)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested	Proceeds from sales of property, businesses and consolidated companies, net of cash divested	57		4		Proceeds from sales of property, businesses and consolidated companies, net of cash divested	59		5
Acquisitions of property and businesses, net of cash acquired	Acquisitions of property and businesses, net of cash acquired	(23)		—		Acquisitions of property and businesses, net of cash acquired	(54)		—
Investments in and loans to nonconsolidated affiliates	Investments in and loans to nonconsolidated affiliates	—		(6)		Investments in and loans to nonconsolidated affiliates	(2)		(33)
Distributions and loan repayments from nonconsolidated affiliates	Distributions and loan repayments from nonconsolidated affiliates	1		—		Distributions and loan repayments from nonconsolidated affiliates	1		10
Proceeds from sales of ownership interests in nonconsolidated affiliates	Proceeds from sales of ownership interests in nonconsolidated affiliates	—		11		Proceeds from sales of ownership interests in nonconsolidated affiliates	63		11
Purchases of investments	Purchases of investments	(165)		(148)		Purchases of investments	(821)		(278)
Proceeds from sales and maturities of investments	Proceeds from sales and maturities of investments	512		141		Proceeds from sales and maturities of investments	1,083		418
Other investing activities, net	Other investing activities, net	(35)		(15)		Other investing activities, net	(35)		(41)
Cash used for investing activities	Cash used for investing activities	(150)		(367)		Cash used for investing activities	(834)		(763)
Financing Activities	Financing Activities					Financing Activities
Changes in short-term notes payable	Changes in short-term notes payable	(91)		(21)		Changes in short-term notes payable	(255)		180

Payments on short-term debt greater than three months	Payments on short-term debt greater than three months	—		(14)		Payments on short-term debt greater than three months	—		(14)

Proceeds from issuance of long-term debt	Proceeds from issuance of long-term debt	13		16		Proceeds from issuance of long-term debt	55		49
Payments on long-term debt	Payments on long-term debt	(156)		(25)		Payments on long-term debt	(320)		(927)
Collections on securitization programs		—		141

Proceeds from issuance of stock	Proceeds from issuance of stock	55		35		Proceeds from issuance of stock	55		97

Transaction financing, debt issuance and other costs						Transaction financing, debt issuance and other costs	(1)		(7)
Employee taxes paid for share-based payment arrangements	Employee taxes paid for share-based payment arrangements	(41)		(35)		Employee taxes paid for share-based payment arrangements	(41)		(34)
Distributions to noncontrolling interests	Distributions to noncontrolling interests	(13)		(1)		Distributions to noncontrolling interests	(36)		(22)

Dividends paid to Dow Inc.	Dividends paid to Dow Inc.	(620)		(1,121)		Dividends paid to Dow Inc.	(1,378)		(2,454)

Cash used for financing activities	Cash used for financing activities	(853)		(1,025)		Cash used for financing activities	(1,921)		(3,132)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(41)		(45)		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(98)		(162)

Summary	Summary					Summary
Increase (decrease) in cash, cash equivalents and restricted cash		(510)		174
Decrease in cash, cash equivalents and restricted cash						Decrease in cash, cash equivalents and restricted cash	(957)		(564)
Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	3,940		3,033		Cash, cash equivalents and restricted cash at beginning of period	3,940		3,033
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	3,430	$	3,207	Cash, cash equivalents and restricted cash at end of period	$	2,983	$	2,469
Less: Restricted cash and cash equivalents, included in "Other current assets"	Less: Restricted cash and cash equivalents, included in "Other current assets"	111		64		Less: Restricted cash and cash equivalents, included in "Other current assets"	59		102
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	3,319	$	3,143	Cash and cash equivalents at end of period	$	2,924	$	2,367

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Equity


		Three Months Ended				Three Months Ended				Six Months Ended
In millions (Unaudited)	In millions (Unaudited)	Mar 31, 2023		Mar 31, 2022			In millions (Unaudited)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Common Stock	Common Stock						Common Stock
Balance at beginning and end of period	Balance at beginning and end of period	$	—	$	—		Balance at beginning and end of period	$	—	$	—	$	—	$	—
Additional Paid-in Capital	Additional Paid-in Capital						Additional Paid-in Capital
Balance at beginning of period	Balance at beginning of period	8,627		8,159			Balance at beginning of period	8,738		8,229		8,627		8,159
Issuance of parent company stock - Dow Inc.	Issuance of parent company stock - Dow Inc.	55		35			Issuance of parent company stock - Dow Inc.	—		62		55		97
Stock-based compensation and allocation of ESOP shares	Stock-based compensation and allocation of ESOP shares	56		35			Stock-based compensation and allocation of ESOP shares	84		84		140		119

Balance at end of period	Balance at end of period	8,738		8,229			Balance at end of period	8,822		8,375		8,822		8,375
Retained Earnings	Retained Earnings						Retained Earnings
Balance at beginning of period	Balance at beginning of period	19,472		19,288			Balance at beginning of period	18,746		19,721		19,472		19,288
Net income (loss) available for The Dow Chemical Company common stockholder		(100)		1,561
Net income available for The Dow Chemical Company common stockholder							Net income available for The Dow Chemical Company common stockholder	487		1,667		387		3,228
Dividends to Dow Inc.	Dividends to Dow Inc.	(620)		(1,121)			Dividends to Dow Inc.	(758)		(1,333)		(1,378)		(2,454)
Other	Other	(6)		(7)			Other	(6)		(6)		(12)		(13)
Balance at end of period	Balance at end of period	18,746		19,721			Balance at end of period	18,469		20,049		18,469		20,049
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss						Accumulated Other Comprehensive Loss
Balance at beginning of period	Balance at beginning of period	(7,139)		(8,977)			Balance at beginning of period	(7,065)		(8,796)		(7,139)		(8,977)
Other comprehensive income		74		181
Other comprehensive income (loss)							Other comprehensive income (loss)	(2)		(408)		72		(227)
Balance at end of period	Balance at end of period	(7,065)		(8,796)			Balance at end of period	(7,067)		(9,204)		(7,067)		(9,204)
Unearned ESOP Shares	Unearned ESOP Shares						Unearned ESOP Shares
Balance at beginning of period	Balance at beginning of period	—		(15)			Balance at beginning of period	—		—		—		(15)

Allocation of ESOP shares	Allocation of ESOP shares	—		15			Allocation of ESOP shares	—		—		—		15
Balance at end of period	Balance at end of period	—		—			Balance at end of period	—		—		—		—
The Dow Chemical Company's stockholder's equity	The Dow Chemical Company's stockholder's equity	20,419		19,154			The Dow Chemical Company's stockholder's equity	20,224		19,220		20,224		19,220
Noncontrolling Interests	Noncontrolling Interests	534		545			Noncontrolling Interests	512		534		512		534
Total Equity	Total Equity	$	20,953	$	19,699		Total Equity	$	20,736	$	19,754	$	20,736	$	19,754

See Notes to the Consolidated Financial Statements.

Table of Contents


Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries (Unaudited)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents


Note	Note		Page	Note		Page
1	1	Consolidated Financial Statements	15	1	Consolidated Financial Statements	15
2	2	Recent Accounting Guidance	16	2	Recent Accounting Guidance	16
3	3	Revenue	16	3	Revenue	16
4	4	Restructuring and Asset Related Charges - Net	18	4	Restructuring and Asset Related Charges - Net	18
5	5	Supplementary Information	19	5	Supplementary Information	19
6	6	Earnings Per Share Calculations	20	6	Earnings Per Share Calculations	20
7	7	Inventories	20	7	Inventories	21
8	8	Commitments and Contingencies	21	8	Commitments and Contingencies	21
9	9	Leases	22	9	Leases	22
10	10	Accumulated Other Comprehensive Loss	23	10	Accumulated Other Comprehensive Loss	23
11	11	Noncontrolling Interests	24	11	Noncontrolling Interests	24
12	12	Pension and Other Postretirement Benefit Plans	24	12	Pension and Other Postretirement Benefit Plans	24
13	13	Stock-Based Compensation	25	13	Stock-Based Compensation	25
14	14	Financial Instruments	26	14	Financial Instruments	25
15	15	Fair Value Measurements	31	15	Fair Value Measurements	29
16	16	Segments and Geographic Regions	32	16	Segments and Geographic Regions	31

NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS

Basis of Presentation

Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 10-K").

As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company.

Table of Contents

NOTE 2 – RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In the first quarter of 2023, the Company adopted the interim period disclosure requirements of Accounting Standards Update ("ASU") 2022-04, "Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations." The ASU, issued in September 2022, requires disclosures intended to enhance the transparency of supplier finance programs. Specifically, the amendments require buyers in a supplier finance program to disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for disclosure of rollforward information, which is required to be disclosed annually and is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The amendments should be applied retrospectively to each period in which a balance sheet is presented, except for disclosure of rollforward information, which should be applied prospectively. The Company expects to early adopt the annual requirement to disclose rollforward information prospectively beginning in the 2023 annual financial statements. See Note 5 for disclosures related to the Company's supplier finance program.

Accounting Guidance Issued But Not Adopted at ~~March 31,~~June 30, 2023

In March 2023, the Financial Accounting Standards Board issued ASU 2023-02, "Investments — Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method." The amendments permit reporting entities to elect to account for their tax equity investments using the proportional amortization method if certain conditions are met. Under the proportional amortization method, an entity amortizes the initial cost of the investment in proportion to the income tax credits and other income tax benefits received and recognizes the net amortization and income tax credits and other income tax benefits in the income statement as a component of income tax expense (benefit). The amendments also require certain disclosures in annual and interim reporting periods about an entity's tax credit programs. The new standard is effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and the amendments must be applied on either a modified retrospective or a retrospective basis. Early adoption is permitted. The Company is currently evaluating early adoption of the new guidance in 2023 and the adoption is not expected to have a material impact on the consolidated financial statements.

NOTE 3 – REVENUE

Revenue Recognition

The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 98 percent and 99 percent for the three months ~~ended March 31, 2023~~ and ~~March 31, 2022.~~six months ended June 30, 2023 (99 percent for the threemonths and six months ended June 30, 2022). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At ~~March 31,~~June 30, 2023, the Company had unfulfilled performance obligations of ~~$963~~$867 million ($840 million at December 31, 2022) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next seven years.

The remaining performance obligations are for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the right to invoice practical expedient, or variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 17 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Table of Contents

Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:


Net Trade Sales by Segment and Business	Net Trade Sales by Segment and Business	Three Months Ended				Net Trade Sales by Segment and Business	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Hydrocarbons & Energy	Hydrocarbons & Energy	$	1,874	$	2,416			Hydrocarbons & Energy	$	1,672	$	2,779	$	3,546	$	5,195
Packaging and Specialty Plastics	Packaging and Specialty Plastics	4,240		5,211				Packaging and Specialty Plastics	4,268		5,454		8,508		10,665
Packaging & Specialty Plastics	Packaging & Specialty Plastics	$	6,114	$	7,627			Packaging & Specialty Plastics	$	5,940	$	8,233	$	12,054	$	15,860
Industrial Solutions	Industrial Solutions	$	1,139	$	1,515			Industrial Solutions	$	1,084	$	1,446	$	2,223	$	2,961
Polyurethanes & Construction Chemicals	Polyurethanes & Construction Chemicals	2,234		3,005				Polyurethanes & Construction Chemicals	2,090		2,919		4,324		5,924
Other	Other	5		4				Other	3		5		8		9
Industrial Intermediates & Infrastructure	Industrial Intermediates & Infrastructure	$	3,378	$	4,524			Industrial Intermediates & Infrastructure	$	3,177	$	4,370	$	6,555	$	8,894
Coatings & Performance Monomers	Coatings & Performance Monomers	$	858	$	1,075			Coatings & Performance Monomers	$	875	$	1,129	$	1,733	$	2,204
Consumer Solutions	Consumer Solutions	1,418		1,974				Consumer Solutions	1,322		1,874		2,740		3,848
Performance Materials & Coatings	Performance Materials & Coatings	$	2,276	$	3,049			Performance Materials & Coatings	$	2,197	$	3,003	$	4,473	$	6,052
Corporate	Corporate	$	83	$	64			Corporate	$	106	$	58	$	189	$	122
Total	Total	$	11,851	$	15,264			Total	$	11,420	$	15,664	$	23,271	$	30,928


Net Trade Sales by Geographic Region	Net Trade Sales by Geographic Region	Three Months Ended				Net Trade Sales by Geographic Region	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
U.S. & Canada	U.S. & Canada	$	4,450	$	5,537			U.S. & Canada	$	4,249	$	5,707	$	8,699	$	11,244
EMEAI 1	EMEAI 1	4,053		5,512				EMEAI 1	3,774		5,677		7,827		11,189
Asia Pacific	Asia Pacific	2,047		2,753				Asia Pacific	2,058		2,673		4,105		5,426
Latin America	Latin America	1,301		1,462				Latin America	1,339		1,607		2,640		3,069
Total	Total	$	11,851	$	15,264			Total	$	11,420	$	15,664	$	23,271	$	30,928

1.Europe, Middle East, Africa and India.

Contract Assets and Liabilities

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

Revenue recognized in the first ~~three~~six months of 2023 from amounts included in contract liabilities at the beginning of the period was approximately ~~$40~~$175 million (approximately ~~$65~~$105 million in the first ~~three~~six months of 2022). In the first ~~three~~six months of 2023, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was approximately ~~$30~~$45 million (insignificant in the first ~~three~~six months of 2022).

Table of Contents

The following table summarizes contract assets and liabilities at ~~March 31,~~June 30, 2023 and December 31, 2022:


Contract Assets and Liabilities	Contract Assets and Liabilities	Balance Sheet Classification	Mar 31, 2023		Dec 31, 2022		Contract Assets and Liabilities	Balance Sheet Classification	Jun 30, 2023		Dec 31, 2022
In millions	In millions						In millions
Accounts and notes receivable - trade	Accounts and notes receivable - trade		$	5,740	$	5,611	Accounts and notes receivable - trade		$	5,539	$	5,611
Contract assets - current	Contract assets - current	Other current assets	$	21	$	48	Contract assets - current	Other current assets	$	15	$	48
Contract assets - noncurrent	Contract assets - noncurrent	Deferred charges and other assets	$	16	$	16	Contract assets - noncurrent	Deferred charges and other assets	$	3	$	16
Contract liabilities - current	Contract liabilities - current	Accrued and other current liabilities	$	293	$	275	Contract liabilities - current	Accrued and other current liabilities	$	207	$	275
Contract liabilities - noncurrent	Contract liabilities - noncurrent	Other noncurrent obligations	$	1,740	$	1,725	Contract liabilities - noncurrent	Other noncurrent obligations	$	1,725	$	1,725

NOTE 4 – RESTRUCTURING AND ASSET RELATED CHARGES - NET

Charges for restructuring programs and other asset related charges, which includes asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's restructuring programs, see Note 5 to the Consolidated Financial Statements included in the 2022 10-K.

2023 Restructuring Program

On January 25, 2023, the Dow Inc. Board of Directors ("Board") approved restructuring actions to achieve the Company's structural cost improvement initiatives in response to the continued economic impact from the global recessionary environment and to enhance its agility and long-term competitiveness across the economic cycle. As a result of these actions, the Company recorded pretax restructuring charges of $541 million in the first quarter of 2023 and additional pretax restructuring charges of $8 million in the second quarter of 2023. These actions are expected to be substantially complete by the end of 2024. The following table summarizes the activities related to the 2023 Restructuring Program, including segment information:


2023 Restructuring Program	2023 Restructuring Program	Severance and Related Benefit Costs		Asset Write-downs and Write-offs			Total		2023 Restructuring Program	Severance and Related Benefit Costs		Asset Write-downs and Write-offs		Total
In millions	In millions					Total			Severance and Related Benefit Costs
Packaging & Specialty Plastics	Packaging & Specialty Plastics	$	—	$	1		$	1		$	—	$	1	$	1
Industrial Intermediates & Infrastructure	Industrial Intermediates & Infrastructure	—		40			40		Industrial Intermediates & Infrastructure	—		40		40
Performance Materials & Coatings	Performance Materials & Coatings	—		49			49		Performance Materials & Coatings	—		49		49
Corporate	Corporate	344		107			451		Corporate	344		107		451
Total restructuring charges	Total restructuring charges	$	344	$	197		$	541	Total restructuring charges	$	344	$	197	$	541
Charges against the reserve	Charges against the reserve	—		(197)			(197)		Charges against the reserve	—		(197)		(197)
Cash payments	Cash payments	(11)		—			(11)		Cash payments	(11)		—		(11)
Reserve balance at Mar 31, 2023	Reserve balance at Mar 31, 2023	$	333	$	—		$	333	Reserve balance at Mar 31, 2023	$	333	$	—	$	333
Industrial Intermediates & Infrastructure									Industrial Intermediates & Infrastructure	$	—	$	8	$	8
Total restructuring charges									Total restructuring charges	$	—	$	8	$	8
Charges against the reserve									Charges against the reserve	—		(8)		(8)
Cash payments									Cash payments	(60)		—		(60)
Reserve balance at Jun 30, 2023									Reserve balance at Jun 30, 2023	$	273	$	—	$	273

At ~~March 31,~~June 30, 2023, ~~$256~~$208 million of the reserve balance was included in "Accrued and other current liabilities" and ~~$77~~$65 million was included in "Other noncurrent obligations" in the consolidated balance sheets.

The Company recorded pretax restructuring charges of $549 million inception-to-date under the 2023 Restructuring Program, consisting of severance and related benefit costs of $344 million and asset write-downs and write-offs of $205 million.

Table of Contents

Severance and Related Benefit Costs

Severance benefits are provided to employees primarily under Dow's ongoing benefit arrangements and are accrued against the Corporate segment once management commits to a plan of termination. The 2023 Restructuring Program included a charge for severance and related benefit costs of $344 million for a global workforce reduction of approximately 2,000 ~~employees. A majority of~~employees, with separations ~~are intended to occur by the end of the second quarter of 2023 with the remaining occurring~~continuing primarily through the end of 2024.

~~Table of Contents~~

Asset Write-downs and Write-offs

The ~~restructuring charge~~2023 Restructuring Program included charges related to the write-down and write-off of assets ~~in the first quarter of 2023 totaled $197~~totaling $205 million. Details regarding the asset write-downs and write-offs are as follows:

•Industrial Intermediates & Infrastructure charges relate to the shutdown of certain polyurethanes assets and the write-off of other assets. The majority of the impacted facilities are expected to be shutdown by the end of 2024.

•Performance Materials & Coatings recorded charges to rationalize its asset footprint by shutting down certain coatings assets. These facilities are expected to be shutdown by the end of 2024.

•Corporate recorded charges related to the write-down of Company owned and leased, non-manufacturing facilities, primarily related to office space rationalization.

Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions, and costs associated with the Company's efficiency actions, are expected to result in additional cash expenditures of approximately ~~$425~~$340 million, primarily through the end of 2024.

2022 Asset Related Charges

In the first quarter of 2022, the Company recorded pretax asset related charges of $186 million due to the Russia and Ukraine conflict and the expectation that certain assets will not be recoverable. These charges included the write-down of inventory, the recording of bad debt reserves and the impairment of other assets. Asset related charges by segment were as follows: $31 million in Packaging & Specialty Plastics, $109 million in Industrial Intermediates & Infrastructure, $16 million in Performance Materials & Coatings and $30 million in Corporate.

NOTE 5 – SUPPLEMENTARY INFORMATION


Dow Inc. Sundry Income (Expense) – Net	Dow Inc. Sundry Income (Expense) – Net	Three Months Ended				Dow Inc. Sundry Income (Expense) – Net	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Non-operating pension and other postretirement benefit plan net credits 1	Non-operating pension and other postretirement benefit plan net credits 1	$	96	$	89			Non-operating pension and other postretirement benefit plan net credits 1	$	97	$	89	$	193	$	178
Foreign exchange gains (losses) 2		(102)		2

Foreign exchange losses 2								Foreign exchange losses 2	(95)		(17)		(197)		(15)

Gain on sales of other assets and investments 3	Gain on sales of other assets and investments 3	65		31				Gain on sales of other assets and investments 3	9		12		74		43
Asset impairments and related costs 4	Asset impairments and related costs 4	(18)		—				Asset impairments and related costs 4	—		—		(18)		—

Indemnification and other transaction related costs 5	Indemnification and other transaction related costs 5	9		12				Indemnification and other transaction related costs 5	(13)		(8)		(4)		4
Loss on early extinguishment of debt								Loss on early extinguishment of debt	—		(8)		—		(8)
Other - net	Other - net	29		14				Other - net	33		7		62		21
Total sundry income (expense) – net	Total sundry income (expense) – net	$	79	$	148			Total sundry income (expense) – net	$	31	$	75	$	110	$	223

1.See Note 12 for additional information.

2.Foreign exchange losses for the three and six months ended ~~March 31,~~June 30, 2023 and June 30, 2022 relate primarily to exposures in the Argentinian peso.

3.~~Includes~~The six months ended June 30, 2023 includes gains associated with the sale of shares of a previously impaired equity method investment.

4.Certain obligations associated with a previously impaired equity method investment.

5.Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution.

Sundry income (expense) - net for TDCC for the three and six months ended ~~March 31,~~June 30, 2023 and 2022 is substantially the same as that of Dow Inc. and therefore is not disclosed separately.

Table of Contents

Supplier Finance Program

The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At ~~March 31,~~June 30, 2023, outstanding obligations confirmed as valid under the SCF program were ~~$290~~$311 million ($267 million at December 31, 2022), included in “Accounts payable – Trade” in the consolidated balance sheets.

~~Table of Contents~~

NOTE 6 - EARNINGS PER SHARE CALCULATIONS

The following tables provide earnings per share calculations for Dow Inc. for the three and six months ended ~~March 31,~~June 30, 2023 and 2022. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

Net Income (Loss) for Earnings Per Share Calculations Three Months Ended
In millions Mar 31, 2023 Mar 31, 2022
Net income (loss) $ (73) $ 1,552
Net income (loss) attributable to noncontrolling interests 20 (17)
Net income attributable to participating securities 1
3 8
Net income (loss) attributable to common stockholders $ (96) $ 1,561


Net Income for Earnings Per Share Calculations	Three Months Ended				Six Months Ended
In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022

Net income	$	501	$	1,681	$	428	$	3,233
Net income attributable to noncontrolling interests	16		20		36		3
Net income attributable to participating securities 1	3		9		6		17
Net income attributable to common stockholders	$	482	$	1,652	$	386	$	3,213

Earnings (Loss) Per Share - Basic and Diluted Three Months Ended
Dollars per share Mar 31, 2023 Mar 31, 2022
Earnings (loss) per common share - basic $ (0.13) $ 2.12
Earnings (loss) per common share - diluted $ (0.13) $ 2.11


Earnings Per Share - Basic and Diluted	Three Months Ended				Six Months Ended
Dollars per share	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Dollars per share	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Earnings per common share - basic	$	0.68	$	2.28	$	0.55	$	4.40
Earnings per common share - diluted	$	0.68	$	2.26	$	0.54	$	4.37


Share Count Information	Share Count Information	Three Months Ended		Share Count Information	Three Months Ended			Six Months Ended
Shares in millions	Shares in millions	Mar 31, 2023	Mar 31, 2022			Shares in millions	Jun 30, 2023	Jun 30, 2022	Jun 30, 2023	Jun 30, 2022
											Jun 30, 2022	Jun 30, 2023	Jun 30, 2022
Weighted-average common shares outstanding - basic	Weighted-average common shares outstanding - basic	708.2	734.6			Weighted-average common shares outstanding - basic	707.0	725.7	707.6	730.2
Plus dilutive effect of equity compensation plans 2		—	5.2
Plus dilutive effect of equity compensation plans						Plus dilutive effect of equity compensation plans	2.9	5.8	3.1	5.4
Weighted-average common shares outstanding - diluted	Weighted-average common shares outstanding - diluted	708.2	739.8			Weighted-average common shares outstanding - diluted	709.9	731.5	710.7	735.6
Stock options and restricted stock units excluded from EPS calculations 3		22.1	6.8
Stock options and restricted stock units excluded from EPS calculations 2						Stock options and restricted stock units excluded from EPS calculations 2	12.3	4.0	10.0	5.4

1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.

2.~~The three months ended March 31, 2023 reflect a net loss, and as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.~~

3.These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

Table of Contents

NOTE 7 – INVENTORIES

The following table provides a breakdown of inventories:


Inventories	Inventories	Mar 31, 2023		Dec 31, 2022		Inventories	Jun 30, 2023		Dec 31, 2022
In millions	In millions					In millions
Finished goods	Finished goods	$	3,974	$	4,150	Finished goods	$	3,741	$	4,150
Work in process	Work in process	1,458		1,476		Work in process	1,262		1,476
Raw materials	Raw materials	867		954		Raw materials	815		954
Supplies	Supplies	911		892		Supplies	935		892
Total	Total	$	7,210	$	7,472	Total	$	6,753	$	7,472
Adjustment of inventories to the LIFO basis	Adjustment of inventories to the LIFO basis	(385)		(484)		Adjustment of inventories to the LIFO basis	(266)		(484)
Total inventories	Total inventories	$	6,825	$	6,988	Total inventories	$	6,487	$	6,988

~~Table of Contents~~

NOTE 8 – COMMITMENTS AND CONTINGENCIES

A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated Financial Statements included in the 2022 10-K, which is incorporated by reference herein.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At ~~March 31,~~June 30, 2023, the Company had accrued obligations of ~~$1,233~~$1,236 million for probable environmental remediation and restoration costs ($1,192 million at December 31, 2022), including ~~$254~~$261 million for the remediation of Superfund sites ($244 million at December 31, 2022). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.

Litigation

Asbestos-Related Matters of Union Carbide Corporation

Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2023 activity, it was determined that no adjustment to the accrual was required at ~~March 31,~~June 30, 2023.

Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was ~~$929~~$904 million at ~~March 31,~~June 30, 2023 ($947 million at December 31, 2022). At ~~March 31,~~June 30, 2023, approximately 2526 percent of the recorded claim liability related to pending claims and approximately 7574 percent related to future claims.

Groundwater Contamination

The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Legacy Liabilities"). The costs associated with these Legacy Liabilities were previously covered by insurance policies that have since been depleted. In the first quarter of 2023, the Company completed a study of the Legacy Liabilities now deemed to be probable and

Table of Contents

estimable based on the public reporting of sampling data and historical information to develop a reasonable estimate of the cost of pending and future claims. As a result, the Company recorded a pretax charge of $177 million, included in "Cost of sales" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure. At ~~March 31,~~June 30, 2023, the total liability related to such alleged Legacy Liabilities settlements was $237 million, which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets.

Indemnifications with Corning Incorporated

The Company had indemnification assets with Corning Incorporated of ~~$99~~$113 million at ~~March 31,~~June 30, 2023 ($98 million at December 31, 2022) related to the 2016 ownership restructure of Dow Silicones, which were included primarily in "Noncurrent receivables" in the consolidated balance sheets.

~~Table of Contents~~

Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter

As a result of a 2019 damages judgment related to the ethylene asset matter, Nova was ordered to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars), for which the Company received payment in October 2019 and March 2020. At ~~March 31,~~June 30, 2023, $323 million ($323 million at December 31, 2022) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment.

NOTE 9 - LEASES

For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included in the 2022 10-K.

The components of lease cost for operating and finance leases for the three and sixmonths ended ~~March 31,~~June 30, 2023 and 2022 were as follows:


Lease Cost	Lease Cost	Three Months Ended				Lease Cost	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Operating lease cost	Operating lease cost	$	98	$	97			Operating lease cost	$	103	$	99	$	201	$	196
Finance lease cost	Finance lease cost							Finance lease cost
Amortization of right-of-use assets - finance	Amortization of right-of-use assets - finance	$	26	$	26			Amortization of right-of-use assets - finance	$	25	$	26	$	51	$	52
Interest on lease liabilities - finance	Interest on lease liabilities - finance	8		8				Interest on lease liabilities - finance	8		9		16		17
Total finance lease cost	Total finance lease cost	$	34	$	34			Total finance lease cost	$	33	$	35	$	67	$	69
Short-term lease cost	Short-term lease cost	66		59				Short-term lease cost	66		66		132		125
Variable lease cost	Variable lease cost	181		115				Variable lease cost	261		133		442		248
Sublease income	Sublease income	(2)		(3)				Sublease income	(2)		(3)		(4)		(6)
Total lease cost	Total lease cost	$	377	$	302			Total lease cost	$	461	$	330	$	838	$	632

The following table provides supplemental cash flow and other information related to leases:

Other Lease Information Three Months Ended
In millions Mar 31, 2023 Mar 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases $ 105 $ 101
Operating cash flows for finance leases $ 8 $ 8
Financing cash flows for finance leases $ 28 $ 22
Right-of-use assets obtained in exchange for lease obligations:
Operating leases $ 99 $ 16
Finance leases $ 6 $ 17


Other Lease Information	Six Months Ended
In millions	Jun 30, 2023		Jun 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	205	$	196
Operating cash flows for finance leases	$	16	$	17
Financing cash flows for finance leases	$	56	$	53
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	199	$	37
Finance leases	$	10	$	27

Table of Contents

NOTE 10 – ACCUMULATED OTHER COMPREHENSIVE LOSS

The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and six months ended ~~March 31,~~June 30, 2023 and 2022 were as follows:


Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss	Three Months Ended				Accumulated Other Comprehensive Loss	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Unrealized Gains (Losses) on Investments	Unrealized Gains (Losses) on Investments							Unrealized Gains (Losses) on Investments
Beginning balance	Beginning balance	$	(253)	$	59			Beginning balance	$	(222)	$	(37)	$	(253)	$	59
Unrealized gains (losses) on investments	Unrealized gains (losses) on investments	30		(121)				Unrealized gains (losses) on investments	58		(203)		88		(324)
Tax (expense) benefit	Tax (expense) benefit	—		24				Tax (expense) benefit	39		43		39		67
Net unrealized gains (losses) on investments	Net unrealized gains (losses) on investments	30		(97)				Net unrealized gains (losses) on investments	97		(160)		127		(257)
(Gains) losses reclassified from AOCL to net income (loss) 1		1		1
(Gains) losses reclassified from AOCL to net income 1								(Gains) losses reclassified from AOCL to net income 1	(46)		9		(45)		10
Tax expense (benefit) 2	Tax expense (benefit) 2	—		—				Tax expense (benefit) 2	10		(2)		10		(2)
Net (gains) losses reclassified from AOCL to net income (loss)		1		1
Net (gains) losses reclassified from AOCL to net income								Net (gains) losses reclassified from AOCL to net income	(36)		7		(35)		8
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	31		(96)				Other comprehensive income (loss), net of tax	61		(153)		92		(249)
Ending balance	Ending balance	$	(222)	$	(37)			Ending balance	$	(161)	$	(190)	$	(161)	$	(190)
Cumulative Translation Adjustment	Cumulative Translation Adjustment							Cumulative Translation Adjustment
Beginning balance	Beginning balance	$	(1,934)	$	(1,355)			Beginning balance	$	(1,833)	$	(1,519)	$	(1,934)	$	(1,355)
Gains (losses) on foreign currency translation	Gains (losses) on foreign currency translation	84		(165)				Gains (losses) on foreign currency translation	(84)		(500)		—		(665)
Tax (expense) benefit	Tax (expense) benefit	2		13				Tax (expense) benefit	(12)		(3)		(10)		10
Net gains (losses) on foreign currency translation	Net gains (losses) on foreign currency translation	86		(152)				Net gains (losses) on foreign currency translation	(96)		(503)		(10)		(655)
(Gains) losses reclassified from AOCL to net income (loss) 3		15		(12)
(Gains) losses reclassified from AOCL to net income 3								(Gains) losses reclassified from AOCL to net income 3	(7)		(11)		8		(23)
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	101		(164)				Other comprehensive income (loss), net of tax	(103)		(514)		(2)		(678)
Ending balance	Ending balance	$	(1,833)	$	(1,519)			Ending balance	$	(1,936)	$	(2,033)	$	(1,936)	$	(2,033)
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits							Pension and Other Postretirement Benefits
Beginning balance	Beginning balance	$	(4,877)	$	(7,334)			Beginning balance	$	(4,871)	$	(7,225)	$	(4,877)	$	(7,334)
Gains (losses) arising during the period	Gains (losses) arising during the period	2		2				Gains (losses) arising during the period	(5)		3		(3)		5

Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) 4		3		157
Amortization of net loss and prior service credits reclassified from AOCL to net income 4								Amortization of net loss and prior service credits reclassified from AOCL to net income 4	2		156		5		313
Tax expense (benefit) 2	Tax expense (benefit) 2	1		(50)				Tax expense (benefit) 2	(1)		(37)		—		(87)
Net loss and prior service credits reclassified from AOCL to net income (loss)		4		107
Net loss and prior service credits reclassified from AOCL to net income								Net loss and prior service credits reclassified from AOCL to net income	1		119		5		226
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	6		109				Other comprehensive income (loss), net of tax	(4)		122		2		231
Ending balance	Ending balance	$	(4,871)	$	(7,225)			Ending balance	$	(4,875)	$	(7,103)	$	(4,875)	$	(7,103)
Derivative Instruments	Derivative Instruments							Derivative Instruments
Beginning balance	Beginning balance	$	(75)	$	(347)			Beginning balance	$	(139)	$	(15)	$	(75)	$	(347)
Gains (losses) on derivative instruments	Gains (losses) on derivative instruments	(183)		420				Gains (losses) on derivative instruments	(1)		260		(184)		680
Tax (expense) benefit	Tax (expense) benefit	33		(56)				Tax (expense) benefit	3		(27)		36		(83)
Net gains (losses) on derivative instruments	Net gains (losses) on derivative instruments	(150)		364				Net gains (losses) on derivative instruments	2		233		(148)		597
(Gains) losses reclassified from AOCL to net income (loss) 5		109		(34)
(Gains) losses reclassified from AOCL to net income 5								(Gains) losses reclassified from AOCL to net income 5	55		(108)		164		(142)
Tax expense (benefit) 2	Tax expense (benefit) 2	(23)		2				Tax expense (benefit) 2	(13)		12		(36)		14
Net (gains) losses reclassified from AOCL to net income (loss)		86		(32)
Net (gains) losses reclassified from AOCL to net income								Net (gains) losses reclassified from AOCL to net income	42		(96)		128		(128)
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	(64)		332				Other comprehensive income (loss), net of tax	44		137		(20)		469
Ending balance	Ending balance	$	(139)	$	(15)			Ending balance	$	(95)	$	122	$	(95)	$	122
Total AOCL ending balance	Total AOCL ending balance	$	(7,065)	$	(8,796)			Total AOCL ending balance	$	(7,067)	$	(9,204)	$	(7,067)	$	(9,204)

1.Reclassified to "Net sales" and "Sundry income (expense) - net."

2.Reclassified to "Provision ~~(credit)~~ for income taxes."

3.Reclassified to "Sundry income (expense) - net."

4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 12 for additional information.

5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

Table of Contents

NOTE 11 – NONCONTROLLING INTERESTS

Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three and six months ended ~~March 31,~~June 30, 2023 and 2022:


Noncontrolling Interests	Noncontrolling Interests	Three Months Ended				Noncontrolling Interests	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Balance at beginning of period	Balance at beginning of period	$	529	$	574			Balance at beginning of period	$	534	$	545	$	529	$	574
Net income (loss) attributable to noncontrolling interests 1		20		(17)
Net income attributable to noncontrolling interests 1								Net income attributable to noncontrolling interests 1	16		20		36		3

Distributions to noncontrolling interests		(13)		(1)
Distributions to noncontrolling interests 2								Distributions to noncontrolling interests 2	(15)		(14)		(28)		(15)

Cumulative translation adjustments	Cumulative translation adjustments	(3)		(11)				Cumulative translation adjustments	(22)		(16)		(25)		(27)
Other	Other	1		—				Other	(1)		(1)		—		(1)
Balance at end of period	Balance at end of period	$	534	$	545			Balance at end of period	$	512	$	534	$	512	$	534

1.The first quarter of 2022 includes the portion of asset related charges attributable to noncontrolling interests related to a joint venture in Russia. See Note 4 for additional information.

2.Includes dividends paid to a joint venture of $8 million for the three and six months ended June 30, 2023 ($7 million for the three and six months ended June 30, 2022) which were reclassified to "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income.

NOTE 12 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the Consolidated Financial Statements included in the 2022 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:


Net Periodic Benefit Cost (Credit) for All Significant Plans	Net Periodic Benefit Cost (Credit) for All Significant Plans	Three Months Ended			Net Periodic Benefit Cost (Credit) for All Significant Plans		Three Months Ended				Six Months Ended
In millions	In millions		Mar 31, 2023		Mar 31, 2022			In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Defined Benefit Pension Plans	Defined Benefit Pension Plans							Defined Benefit Pension Plans
Service cost	Service cost		$	70	$	99		Service cost	$	71	$	99	$	141	$	198
Interest cost	Interest cost		279		171			Interest cost	279		171		558		342
Expected return on plan assets	Expected return on plan assets		(389)		(424)			Expected return on plan assets	(390)		(423)		(779)		(847)
Amortization of prior service credit	Amortization of prior service credit		(7)		(6)			Amortization of prior service credit	(6)		(5)		(13)		(11)
Amortization of net loss	Amortization of net loss		24		167			Amortization of net loss	23		165		47		332

Net periodic benefit cost (credit)	Net periodic benefit cost (credit)		$	(23)	$	7		Net periodic benefit cost (credit)	$	(23)	$	7	$	(46)	$	14

Other Postretirement Benefit Plans	Other Postretirement Benefit Plans							Other Postretirement Benefit Plans
Service cost	Service cost		$	1	$	1		Service cost	$	1	$	2	$	2	$	3
Interest cost	Interest cost		11		7			Interest cost	12		7		23		14
Amortization of net gain	Amortization of net gain		(14)		(4)			Amortization of net gain	(15)		(4)		(29)		(8)

Net periodic benefit cost (credit)	Net periodic benefit cost (credit)		$	(2)	$	4		Net periodic benefit cost (credit)	$	(2)	$	5	$	(4)	$	9

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.

Table of Contents

NOTE 13 – STOCK-BASED COMPENSATION

A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the 2022 10-K.

Stock Incentive Plan

The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.

In the first quarter of 2023, Dow Inc. granted the following stock-based compensation awards to employees:

•1.1 million stock options with a weighted-average exercise price of $59.08 per share and a weighted-average fair value of $12.13 per share;

•1.8 million restricted stock units with a weighted-average fair value of $59.03 per share; and

•1.2 million performance stock units with a weighted-average fair value of $64.04 per share.

There was minimal grant activity in the second quarter of 2023.

Employee Stock Purchase Plan

The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Dow Inc. Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2023 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at May 1, 2023 (beginning) or November 3, 2023 (ending) of the offering period, whichever is lower.

In the second quarter of 2023, employees subscribed to the right to purchase approximately 2.6 million shares under the 2021 ESPP. The plan price is fixed upon the close of the offering period and will be determined in the fourth quarter of 2023. The shares will be delivered to employees in the fourth quarter of 2023.

~~Table of Contents~~

NOTE 14 – FINANCIAL INSTRUMENTS

A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 to the Consolidated Financial Statements included in the 2022 10-K.

~~The following table summarizes~~Refer to Note 15 for a summary of the fair value of financial instruments at ~~March 31,~~June 30, 2023 and December 31, ~~2022:~~

Fair Value of Financial Instruments Mar 31, 2023 Dec 31, 2022
In millions Cost Gain Loss Fair Value Cost Gain Loss Fair Value
Cash equivalents:
Held-to-maturity securities 1
$ 714 $ — $ — $ 714 $ 872 $ — $ — $ 872
Money market funds 1,273 — — 1,273 355 — — 355
Total cash equivalents $ 1,987 $ — $ — $ 1,987 $ 1,227 $ — $ — $ 1,227
Marketable securities 2
$ 610 $ 9 $ — $ 619 $ 927 $ 12 $ — $ 939
Other investments:
Debt securities:
Government debt 3
$ 762 $ 1 $ (122) $ 641 $ 754 $ 1 $ (133) $ 622
Corporate bonds 1,272 9 (134) 1,147 1,274 10 (159) 1,125
Total debt securities $ 2,034 $ 10 $ (256) $ 1,788 $ 2,028 $ 11 $ (292) $ 1,747
Equity securities 4
5 13 — 18 5 5 — 10
Total other investments $ 2,039 $ 23 $ (256) $ 1,806 $ 2,033 $ 16 $ (292) $ 1,757
Total cash equivalents, marketable securities and other investments $ 4,636 $ 32 $ (256) $ 4,412 $ 4,187 $ 28 $ (292) $ 3,923
Long-term debt including debt due within one year 5
$ (14,986) $ 1,389 $ (642) $ (14,239) $ (15,060) $ 1,683 $ (498) $ (13,875)
Derivatives relating to:
Interest rates 6
$ — $ 2 $ — $ 2 $ — $ 105 $ — $ 105
Foreign currency — 66 (17) 49 — 115 (30) 85
Commodities 6
— 24 (30) (6) — 72 (61) 11
Total derivatives $ — $ 92 $ (47) $ 45 $ — $ 292 $ (91) $ 201

1.~~The Company's held-to-maturity securities primarily included treasury bills and time deposits.~~

2.~~The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.~~

3.~~U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.~~

4.~~Equity securities with a readily determinable fair value.~~

5.Cost includes fair value hedge adjustment gains of $49 million at March 31, 2023 and $46 million at December 31, 2022 on $2,729 million of debt at March 31, 2023 and $2,279 million of debt at December 31, 2022.

6.~~Presented net of cash collateral where master netting arrangements allow.~~

~~Cost approximates fair value for all other financial instruments.~~

Debt Securities

The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the ~~three~~six months ended ~~March 31,~~June 30, 2023 and 2022:


Investing Results	Investing Results	Three Months Ended				Investing Results	Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022		In millions	Jun 30, 2023		Jun 30, 2022
Proceeds from sales of available-for-sale securities	Proceeds from sales of available-for-sale securities	$	146	$	113	Proceeds from sales of available-for-sale securities	$	274	$	295
Gross realized gains	Gross realized gains	$	8	$	12	Gross realized gains	$	58	$	20
Gross realized losses	Gross realized losses	$	(9)	$	(13)	Gross realized losses	$	(13)	$	(30)

2625

Table of Contents

The following table summarizes contractual maturities of the Company's investments in debt securities:


Contractual Maturities of Debt Securities at Mar 31, 2023		Cost		Fair Value
Contractual Maturities of Debt Securities at Jun 30, 2023						Contractual Maturities of Debt Securities at Jun 30, 2023	Cost		Fair Value
In millions	In millions	Cost		Fair Value		In millions
Within one year	Within one year					Within one year	$	77	$	74
One to five years	One to five years	894		814		One to five years	897		823
Six to ten years	Six to ten years	550		479		Six to ten years	536		467
After ten years	After ten years	512		419		After ten years	515		418
Total	Total	$	2,034	$	1,788	Total	$	2,025	$	1,782

Equity Securities

There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three months ended ~~March 31,~~June 30, 2023. There was $8$2 million of net unrealized gains recognized in earnings on equity securities for the three months ended ~~March 31,~~June 30, 2023 ($3 million net unrealized loss for the three months ended ~~March 31,~~June 30, 2022). There was $10 million of net unrealized gains recognized in earnings on equity securities for the six months ended June 30, 2023 ($6 million net unrealized loss for the six months ended June 30, 2022).


Investments in Equity Securities	Investments in Equity Securities	Mar 31, 2023		Dec 31, 2022		Investments in Equity Securities	Jun 30, 2023		Dec 31, 2022
In millions	In millions					In millions
Readily determinable fair value	Readily determinable fair value	$	18	$	10	Readily determinable fair value	$	20	$	10
Not readily determinable fair value	Not readily determinable fair value	$	178	$	186	Not readily determinable fair value	$	182	$	186

Derivative Instruments

The notional amounts of the Company's derivative instruments at ~~March 31,~~June 30, 2023 and December 31, 2022 were as follows:


Notional Amounts 1	Notional Amounts 1	Mar 31, 2023		Dec 31, 2022		Notional Amounts 1	Jun 30, 2023		Dec 31, 2022
In millions	In millions					In millions
Derivatives designated as hedging instruments:	Derivatives designated as hedging instruments:					Derivatives designated as hedging instruments:
Interest rate contracts	Interest rate contracts	$	450	$	1,500	Interest rate contracts	$	2,000	$	1,500
Foreign currency contracts	Foreign currency contracts	$	2,141	$	2,408	Foreign currency contracts	$	9,934	$	2,408
Derivatives not designated as hedging instruments:	Derivatives not designated as hedging instruments:					Derivatives not designated as hedging instruments:
Interest rate contracts	Interest rate contracts	$	46	$	3	Interest rate contracts	$	72	$	3
Foreign currency contracts	Foreign currency contracts	$	12,150	$	8,837	Foreign currency contracts	$	14,211	$	8,837

1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at ~~March 31,~~June 30, 2023 and December 31, 2022 were as follows:

Commodity Notionals 1

Mar 31, 2023

Dec 31, 2022

Notional Volume Unit

Commodity Notionals 1

Jun 30, 2023

Dec 31, 2022

Notional Volume Unit

Derivatives designated as hedging instruments:

Hydrocarbon derivatives

8.5

19.2

million barrels of oil equivalent

Hydrocarbon derivatives

2.1

19.2

million barrels of oil equivalent

Derivatives not designated as hedging instruments:

Hydrocarbon derivatives

1.0

—

million barrels of oil equivalent

Hydrocarbon derivatives

1.1

—

million barrels of oil equivalent

Power derivatives

21.3

—

thousands of megawatt hours

1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.

Table of Contents


Maturity Dates of Derivatives Designated as Hedging Instruments			Year
Interest rate contracts			2024
Foreign currency contracts			2024
Commodity contracts			2026

~~Table of Contents~~

The following ~~tables provide~~table provides the fair value and balance sheet classification of derivative instruments at ~~March 31,~~June 30, 2023 and December 31, 2022:


Fair Value of Derivative Instruments	Fair Value of Derivative Instruments		Mar 31, 2023						Fair Value of Derivative Instruments	Jun 30, 2023					Dec 31, 2022
In millions	In millions	Balance Sheet Classification	Gross		Counterparty and Cash Collateral Netting 1		Net Amounts Included in the Consolidated Balance Sheets		In millions		Gross		Counterparty and Cash Collateral Netting 1		Net 2		Gross		Counterparty and Cash Collateral Netting 1		Net 2
Asset derivatives	Asset derivatives								Asset derivatives
Derivatives designated as hedging instruments:	Derivatives designated as hedging instruments:								Derivatives designated as hedging instruments:
Interest rate contracts 3									Interest rate contracts 3		$	—	$	—	$	—	$	351	$	(246)	$	105
Interest rate contracts 4									Interest rate contracts 4		121		(121)		—		—		—		—
Foreign currency contracts 3									Foreign currency contracts 3		114		(70)		44		58		(39)		19

Interest rate contracts		Deferred charges and other assets	$	37	$	(35)	$	2
Foreign currency contracts		Other current assets	32		(32)		—

Commodity contracts		Other current assets	87		(65)		22

Commodity contracts 3									Commodity contracts 3		77		(48)		29		199		(148)		51
Commodity contracts 4									Commodity contracts 4		11		(8)		3		—		—		—
Total	Total		$	156	$	(132)	$	24	Total		$	323	$	(247)	$	76	$	608	$	(433)	$	175
Derivatives not designated as hedging instruments:	Derivatives not designated as hedging instruments:								Derivatives not designated as hedging instruments:
Interest rate contracts		Other current assets	$	2	$	(2)	$	—
Interest rate contracts 3									Interest rate contracts 3		$	2	$	(1)	$	1	$	—	$	—	$	—

Foreign currency contracts		Other current assets	90		(24)		66
Foreign currency contracts 3									Foreign currency contracts 3		65		(16)		49		146		(50)		96

Commodity contracts		Other current assets	2		—		2
Commodity contracts 3									Commodity contracts 3		10		(4)		6		22		(1)		21

Total	Total		$	94	$	(26)	$	68	Total		$	77	$	(21)	$	56	$	168	$	(51)	$	117
Total asset derivatives	Total asset derivatives		$	250	$	(158)	$	92	Total asset derivatives		$	400	$	(268)	$	132	$	776	$	(484)	$	292

Liability derivatives	Liability derivatives								Liability derivatives
Derivatives designated as hedging instruments:	Derivatives designated as hedging instruments:								Derivatives designated as hedging instruments:
Interest rate contracts 5									Interest rate contracts 5		$	—	$	—	$	—	$	246	$	(246)	$	—
Interest rate contracts 6									Interest rate contracts 6		128		(121)		7		—		—		—
Foreign currency contracts 5									Foreign currency contracts 5		70		(70)		—		58		(39)		19

Interest rate contracts		Other noncurrent obligations	$	35	$	(35)	$	—
Foreign currency contracts		Accrued and other current liabilities	41		(32)		9

Commodity contracts		Accrued and other current liabilities	147		(119)		28

Commodity contracts 5									Commodity contracts 5		96		(69)		27		258		(198)		60
Commodity contracts 6									Commodity contracts 6		8		(8)		—		—		—		—
Total	Total		$	223	$	(186)	$	37	Total		$	302	$	(268)	$	34	$	562	$	(483)	$	79
Derivatives not designated as hedging instruments:	Derivatives not designated as hedging instruments:								Derivatives not designated as hedging instruments:
Interest rate contracts		Accrued and other current liabilities	$	2	$	(2)	$	—
Interest rate contracts 5									Interest rate contracts 5		$	2	$	(1)	$	1	$	—	$	—	$	—

Foreign currency contracts		Accrued and other current liabilities	32		(24)		8
Foreign currency contracts 5									Foreign currency contracts 5		25		(16)		9		61		(50)		11

Commodity contracts		Accrued and other current liabilities	2		—		2
Commodity contracts 5									Commodity contracts 5		7		(5)		2		12		(11)		1

Total	Total		$	36	$	(26)	$	10	Total		$	34	$	(22)	$	12	$	73	$	(61)	$	12
Total liability derivatives	Total liability derivatives		$	259	$	(212)	$	47	Total liability derivatives		$	336	$	(290)	$	46	$	635	$	(544)	$	91

1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

2.Represents the net amounts included in the consolidated balance sheets.

3.Included in "Other current assets" in the consolidated balance sheets.

4.Included in "Deferred charges and other assets" in the consolidated balance sheets.

5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.

6.Included in "Other noncurrent obligations" in the consolidated balance sheets.

2827

Table of Contents

Fair Value of Derivative Instruments Dec 31, 2022
In millions Balance Sheet Classification Gross
Counterparty and Cash Collateral Netting 1
Net Amounts Included in the Consolidated Balance Sheets
Asset derivatives
Derivatives designated as hedging instruments:
Interest rate contracts Other current assets $ 351 $ (246) $ 105
Foreign currency contracts Other current assets 58 (39) 19
Commodity contracts Other current assets 199 (148) 51
Total $ 608 $ (433) $ 175
Derivatives not designated as hedging instruments:
Foreign currency contracts Other current assets $ 146 $ (50) $ 96
Commodity contracts Other current assets 22 (1) 21
Total $ 168 $ (51) $ 117
Total asset derivatives $ 776 $ (484) $ 292
Liability derivatives
Derivatives designated as hedging instruments:
Interest rate contracts Accrued and other current liabilities $ 246 $ (246) $ —
Foreign currency contracts Accrued and other current liabilities 58 (39) 19
Commodity contracts Accrued and other current liabilities 258 (198) 60
Total $ 562 $ (483) $ 79
Derivatives not designated as hedging instruments:
Foreign currency contracts Accrued and other current liabilities $ 61 $ (50) $ 11
Commodity contracts Accrued and other current liabilities 12 (11) 1
Total $ 73 $ (61) $ 12
Total liability derivatives $ 635 $ (544) $ 91

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of ~~$77~~$37 million at ~~March 31,~~June 30, 2023 ($80 million at December 31, 2022). No cash collateral was posted by counterparties with the Company at ~~March 31,~~June 30, 2023 ($2 million at December 31, 2022).

~~Table of Contents~~

The following ~~tables summarize~~table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three and six months ended ~~March 31,~~June 30, 2023 and 2022:


Effect of Derivative Instruments	Effect of Derivative Instruments	Amount of gain (loss) recognized in OCI 1				Amount of gain (loss) recognized in income 2				Income Statement Classification	Effect of Derivative Instruments	Gain (loss) recognized in OCI 1								Gain (loss) recognized in income 2
		Three Months Ended				Three Months Ended						Three Months Ended				Six Months Ended				Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022		Mar 31, 2023		Mar 31, 2022			In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Derivatives designated as hedging instruments:	Derivatives designated as hedging instruments:										Derivatives designated as hedging instruments:
Fair value hedges:	Fair value hedges:										Fair value hedges:

Excluded components 3		$	(1)	$	—	$	—	$	—	Interest expense and amortization of debt discount
Excluded components 3, 4											Excluded components 3, 4	$	(4)	$	—	$	(5)	$	—	$	—	$	—	$	—	$	—
Cash flow hedges:	Cash flow hedges:										Cash flow hedges:
Interest rate contracts		5		99		(2)		(3)		Interest expense and amortization of debt discount
Foreign currency contracts		—		2		2		3		Cost of sales
Interest rate contracts 4											Interest rate contracts 4	—		108		5		207		(2)		(2)		(4)		(5)
Foreign currency contracts 5											Foreign currency contracts 5	1		4		1		6		(1)		3		1		6

Commodity contracts		(143)		207		(109)		34		Cost of sales
Commodity contracts 5											Commodity contracts 5	(6)		80		(149)		287		(52)		107		(161)		141
Net foreign investment hedges:	Net foreign investment hedges:										Net foreign investment hedges:
Foreign currency contracts	Foreign currency contracts	(9)		(2)		—		—			Foreign currency contracts	12		49		3		47		—		—		—		—
Excluded components 3		3		29		—		12		Sundry income (expense) - net
Excluded components 3, 6											Excluded components 3, 6	28		5		31		34		7		11		7		23
Total derivatives designated as hedging instruments	Total derivatives designated as hedging instruments	$	(145)	$	335	$	(109)	$	46		Total derivatives designated as hedging instruments	$	31	$	246	$	(114)	$	581	$	(48)	$	119	$	(157)	$	165
Derivatives not designated as hedging instruments:	Derivatives not designated as hedging instruments:										Derivatives not designated as hedging instruments:
Interest rate contracts		$	—	$	—	$	—	$	(1)	Interest expense and amortization of debt discount
Foreign currency contracts		—		—		35		(85)		Sundry income (expense) - net
Commodity contracts		—		—		—		22		Cost of sales
Total return swap		—		—		(7)		—		Cost of sales
Interest rate contracts 4											Interest rate contracts 4	$	—	$	—	$	—	$	—	$	1	$	—	$	1	$	(1)
Foreign currency contracts 6											Foreign currency contracts 6	—		—		—		—		(29)		(191)		6		(276)
Commodity contracts 5											Commodity contracts 5	—		—		—		—		4		7		4		29
Total return swap 5											Total return swap 5	—		—		—		—		10		—		3		—
Total derivatives not designated as hedging instruments	Total derivatives not designated as hedging instruments	$	—	$	—	$	28	$	(64)		Total derivatives not designated as hedging instruments	$	—	$	—	$	—	$	—	$	(14)	$	(184)	$	14	$	(248)
Total derivatives	Total derivatives	$	(145)	$	335	$	(81)	$	(18)		Total derivatives	$	31	$	246	$	(114)	$	581	$	(62)	$	(65)	$	(143)	$	(83)

1.OCI is defined as other comprehensive income (loss).

2.Pretax amounts.

3.The excluded components are related to the time value of the derivatives designated as hedges.

4.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.

5.Included in "Cost of sales" in the consolidated statements of income.

6.Included in "Sundry income (expense) - net" in the consolidated statements of income.

The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:


Expected Reclassifications from AOCL within the next 12 months	~~Mar 31,~~Jun 30, 2023
In millions
Cash flow hedges:
Interest rate contracts	$	(7)
Commodity contracts	$	~~(101)~~(72)
Foreign currency contracts	$	—1
Net foreign investment hedges:
Excluded components	$	325

3028

Table of Contents

NOTE 15 – FAIR VALUE MEASUREMENTS

A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the 2022 10-K.

Fair Value Measurements on a Recurring Basis

The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:


Basis of Fair Value Measurements on a Recurring Basis		Mar 31, 2023								Dec 31, 2022
		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Fair Value Measurements on a Recurring Basis																		Fair Value Measurements on a Recurring Basis		Jun 30, 2023								Dec 31, 2022
In millions	In millions	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total		In millions	Fair Value Level	Cost		Gain		Loss		Fair Value		Cost		Gain		Loss		Fair Value
Assets at fair value:	Assets at fair value:																	Assets at fair value:
Cash equivalents:	Cash equivalents:																	Cash equivalents:
Held-to-maturity securities 1	Held-to-maturity securities 1	$	—	$	714	$	—	$	714	$	—	$	872	$	—	$	872	Held-to-maturity securities 1	Level 2	$	283	$	—	$	—	$	283	$	872	$	—	$	—	$	872
Money market funds	Money market funds	—		1,273		—		1,273		—		355		—		355		Money market funds	Level 2	1,598		—		—		1,598		355		—		—		355
Marketable securities 2	Marketable securities 2	—		619		—		619		—		939		—		939		Marketable securities 2	Level 2	701		15		—		716		927		12		—		939
Equity securities 3		18		—		—		18		10		—		—		10
Nonconsolidated affiliates 4		—		—		7		7		—		—		7		7
Debt securities: 3
Nonconsolidated affiliates 3																		Nonconsolidated affiliates 3	Level 3							7								7
Other investments:																		Other investments:
Debt securities: 4																		Debt securities: 4
Government debt 5	Government debt 5	—		641		—		641		—		622		—		622		Government debt 5	Level 2	799		2		(125)		676		754		1		(133)		622
Corporate bonds	Corporate bonds	31		1,116		—		1,147		35		1,090		—		1,125		Corporate bonds	Level 1	33		—		(3)		30		38		—		(3)		35
Derivatives relating to: 6
Corporate bonds																		Corporate bonds	Level 2	1,193		12		(129)		1,076		1,236		10		(156)		1,090
Equity securities 4, 6																		Equity securities 4, 6	Level 1	5		15		—		20		5		5		—		10
Derivatives relating to: 7																		Derivatives relating to: 7
Interest rates	Interest rates	—		39		—		39		—		351		—		351		Interest rates	Level 2	—		123		—		123		—		351		—		351
Foreign currency	Foreign currency	—		122		—		122		—		204		—		204		Foreign currency	Level 2	—		179		—		179		—		204		—		204
Commodities	Commodities	18		71		—		89		63		158		—		221		Commodities	Level 1	—		33		—		33		—		63		—		63
Commodities																		Commodities	Level 2	—		65		—		65		—		158		—		158
Total assets at fair value	Total assets at fair value	$	67	$	4,595	$	7	$	4,669	$	108	$	4,591	$	7	$	4,706	Total assets at fair value								$	4,806							$	4,706
Liabilities at fair value:	Liabilities at fair value:																	Liabilities at fair value:
Long-term debt including debt due within one year 7		$	—	$	14,239	$	—	$	14,239	$	—	$	13,875	$	—	$	13,875
Guarantee liability 8		—		—		194		194		—		—		199		199
Derivatives relating to: 6
Long-term debt including debt due within one year 8																		Long-term debt including debt due within one year 8	Level 2	$	(14,842)	$	1,532	$	(556)	$	(13,866)	$	(15,060)	$	1,683	$	(498)	$	(13,875)
Guarantee liability 9																		Guarantee liability 9	Level 3							(189)								(199)
Derivatives relating to: 7																		Derivatives relating to: 7
Interest rates	Interest rates	—		37		—		37		—		246		—		246		Interest rates	Level 2	—		—		(130)		(130)		—		—		(246)		(246)
Foreign currency	Foreign currency	—		73		—		73		—		119		—		119		Foreign currency	Level 2	—		—		(95)		(95)		—		—		(119)		(119)
Commodities	Commodities	68		81		—		149		103		167		—		270		Commodities	Level 1	—		—		(34)		(34)				—		(103)		(103)
Commodities																		Commodities	Level 2	—		—		(77)		(77)		—		—		(167)		(167)
Total liabilities at fair value	Total liabilities at fair value	$	68	$	14,430	$	194	$	14,692	$	103	$	14,407	$	199	$	14,709	Total liabilities at fair value								$	(14,391)							$	(14,709)

1.The Company's held-to-maturity securities primarily included treasury bills and time deposits.

2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.

3.Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

4.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” ~~in the consolidated balance sheets.~~

4.~~Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates"~~ in the consolidated balance sheets.

5.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.

6.Equity securities with a readily determinable fair value.

7.See Note 14 for ~~the~~ classification of derivatives in the consolidated balance sheets.

7.8.~~See Note 14 for information on~~Cost includes fair value ~~measurements~~hedge adjustment gains of ~~long-term debt.~~$46 million at June 30, 2023 and December 31, 2022 on $3,729 million of debt at June 30, 2023 and $2,279 million of debt at December 31, 2022.

8.9.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.

Cost approximates fair value for all other financial instruments.

Table of Contents

For equity securities calculated at net asset value per share (or its equivalent), the Company had ~~$84~~$88 million in private market securities and ~~$20~~$19 million in real estate at ~~March 31,~~June 30, 2023 ($($92 million in private market securities and $20 million in real estate at December 31, 2022). There are no redemption restrictions and the unfunded commitments on these investments were $54 million at ~~March 31,~~June 30, 2023 and December 31, 2022.

For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset value represents the fair value of an investment in a limited liability company, accounted for as an investment in nonconsolidated affiliates. There was no unfunded commitment on the investment at ~~March 31,~~June 30, 2023 or December 31, 2022.

~~Table of Contents~~

For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.

Fair Value Measurements on a Nonrecurring Basis

As part of the 2023 Restructuring Program, the Company has or will shut down a number of manufacturing facilities, corporate facilities and miscellaneous assets around the world. In the first quarter of 2023, the assets associated with this plan were written down to zero, except for one corporate facility. The remaining corporate facility, which was classified as a level 3 measurement, was written down to a fair value of $16 million using unobservable inputs. In addition, impairments of leased, non-manufacturing facilities, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to a fair value of $9 million using unobservable inputs. The impairment charges related to the 2023 Restructuring Program, totaling $197 million, were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($1 million), Industrial Intermediates & Infrastructure ($40 million), Performance Materials & Coatings ($49 million) and Corporate ($107 million).

In the second quarter of 2023, the Company recorded an adjustment to the impairment charges related to the 2023 Restructuring Program, totaling $8 million, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

Table of Contents

NOTE 16 – SEGMENTS AND GEOGRAPHIC REGIONS

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the Company's chief operating decision maker assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income ~~(loss)~~ before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.


Segment Information	Segment Information	Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Materials & Coatings		Corp.		Total		Segment Information	Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Materials & Coatings		Corp.		Total
In millions	In millions	Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Materials & Coatings		Corp.		Total		In millions	Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Materials & Coatings		Corp.		Total
Three months ended Mar 31, 2023
Three months ended Jun 30, 2023												Three months ended Jun 30, 2023
Net sales	Net sales	$	6,114	$	3,378	$	2,276	$	83	$	11,851	Net sales	$	5,940	$	3,177	$	2,197	$	106	$	11,420
Equity in earnings (losses) of nonconsolidated affiliates	Equity in earnings (losses) of nonconsolidated affiliates	$	21	$	(73)	$	3	$	1	$	(48)	Equity in earnings (losses) of nonconsolidated affiliates	$	19	$	(83)	$	6	$	1	$	(57)
Dow Inc. Operating EBIT 1	Dow Inc. Operating EBIT 1	$	642	$	123	$	35	$	(92)	$	708	Dow Inc. Operating EBIT 1	$	918	$	(35)	$	66	$	(64)	$	885
Three months ended Mar 31, 2022
Three months ended Jun 30, 2022												Three months ended Jun 30, 2022
Net sales	Net sales	$	7,627	$	4,524	$	3,049	$	64	$	15,264	Net sales	$	8,233	$	4,370	$	3,003	$	58	$	15,664
Equity in earnings (losses) of nonconsolidated affiliates	Equity in earnings (losses) of nonconsolidated affiliates	$	110	$	62	$	3	$	(1)	$	174	Equity in earnings (losses) of nonconsolidated affiliates	$	138	$	57	$	2	$	(2)	$	195
Dow Inc. Operating EBIT 1	Dow Inc. Operating EBIT 1	$	1,234	$	661	$	595	$	(71)	$	2,419	Dow Inc. Operating EBIT 1	$	1,436	$	426	$	561	$	(48)	$	2,375

Six months ended Jun 30, 2023												Six months ended Jun 30, 2023
Net sales												Net sales	$	12,054	$	6,555	$	4,473	$	189	$	23,271
Equity in earnings (losses) of nonconsolidated affiliates												Equity in earnings (losses) of nonconsolidated affiliates	$	40	$	(156)	$	9	$	2	$	(105)
Dow Inc. Operating EBIT 1												Dow Inc. Operating EBIT 1	$	1,560	$	88	$	101	$	(156)	$	1,593
Six months ended Jun 30, 2022												Six months ended Jun 30, 2022
Net sales												Net sales	$	15,860	$	8,894	$	6,052	$	122	$	30,928
Equity in earnings (losses) of nonconsolidated affiliates												Equity in earnings (losses) of nonconsolidated affiliates	$	248	$	119	$	5	$	(3)	$	369
Dow Inc. Operating EBIT 1												Dow Inc. Operating EBIT 1	$	2,670	$	1,087	$	1,156	$	(119)	$	4,794

1.Operating EBIT for TDCC for the three and six months ended ~~March 31,~~June 30, 2023 and 2022 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Net ~~income (loss)"~~income" to Operating EBIT is provided in the following table.


Reconciliation of "Net income (loss)" to Operating EBIT		Three Months Ended
Reconciliation of "Net income" to Operating EBIT						Reconciliation of "Net income" to Operating EBIT	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022		In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net income (loss)		$	(73)	$	1,552
+ Provision (credit) for income taxes		(47)		503
Income (loss) before income taxes		$	(120)	$	2,055
Net income						Net income	$	501	$	1,681	$	428	$	3,233
+ Provision for income taxes						+ Provision for income taxes	210		488		163		991
Income before income taxes						Income before income taxes	$	711	$	2,169	$	591	$	4,224
- Interest income	- Interest income	76		28		- Interest income	66		36		142		64
+ Interest expense and amortization of debt discount	+ Interest expense and amortization of debt discount	185		167		+ Interest expense and amortization of debt discount	172		165		357		332
- Significant items	- Significant items	(719)		(225)		- Significant items	(68)		(77)		(787)		(302)
Operating EBIT	Operating EBIT	$	708	$	2,419	Operating EBIT	$	885	$	2,375	$	1,593	$	4,794

3231

Table of Contents

The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:


Significant Items by Segment	Significant Items by Segment	Three Months Ended Mar 31, 2023												Significant Items by Segment	Three Months Ended Jun 30, 2023							Six Months Ended Jun 30, 2023
		Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Mat. & Coatings		Corp.		Total								Significant Items by Segment	Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Mat. & Coatings		Corp.		Total		Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Mat. & Coatings		Corp.		Total
In millions	In millions											In millions	Pack. & Spec. Plastics		Ind. Interm. & Infrast.	Perf. Mat. & Coatings	Corp.																						Total

Restructuring, implementation and efficiency costs, and asset related charges - net 1	Restructuring, implementation and efficiency costs, and asset related charges - net 1	$	(1)	$	(40)	$	(67)	$	(443)	$	(551)								Restructuring, implementation and efficiency costs, and asset related charges - net 1	$	—	$	(8)	$	—	$	(47)	$	(55)	$	(1)	$	(48)	$	(67)	$	(490)	$	(606)
Litigation related charges, awards and adjustments 2	Litigation related charges, awards and adjustments 2	—		(177)		—		—		(177)									Litigation related charges, awards and adjustments 2	—		—		—		—		—		—		(177)		—		—		(177)

Indemnification and other transaction related costs 3	Indemnification and other transaction related costs 3	—		—		—		9		9									Indemnification and other transaction related costs 3	—		—		—		(13)		(13)		—		—		—		(4)		(4)
Total	Total	$	(1)	$	(217)	$	(67)	$	(434)	$	(719)								Total	$	—	$	(8)	$	—	$	(60)	$	(68)	$	(1)	$	(225)	$	(67)	$	(494)	$	(787)

1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. ~~Also~~The six months ended June 30, 2023 also includes certain gains and losses associated with previously impaired equity investments.

2.Includes a loss associated with legacy agricultural products groundwater contamination matters. See Note 8 for additional information.

3.Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.


Significant Items by Segment	Significant Items by Segment	Three Months Ended Mar 31, 2022												Significant Items by Segment	Three Months Ended Jun 30, 2022										Six Months Ended Jun 30, 2022
		Pack. & Spec. Plastics		Ind. Interm. & Infrast.		Perf. Mat. & Coatings		Corp.		Total								Significant Items by Segment		Pack. & Spec. Plastics			Ind. Interm. & Infrast.			Perf. Mat. & Coatings			Corp.			Total			Pack. & Spec. Plastics			Ind. Interm. & Infrast.			Perf. Mat. & Coatings			Corp.			Total
In millions	In millions											In millions	Pack. & Spec. Plastics		Ind. Interm. & Infrast.	Perf. Mat. & Coatings	Corp.																																	Total
Digitalization program costs 1	Digitalization program costs 1	$	—	$	—	$	—	$	(41)	$	(41)								Digitalization program costs 1		$	—		$	—		$	—		$	(51)		$	(51)		$	—		$	—		$	—		$	(92)		$	(92)
Restructuring, implementation costs and asset related charges - net 2	Restructuring, implementation costs and asset related charges - net 2	—		—		—		(10)		(10)										Restructuring, implementation costs and asset related charges - net 2		—			—			—			(10)			(10)			—			—			—			(20)			(20)
Russia / Ukraine conflict charges 3	Russia / Ukraine conflict charges 3	(31)		(109)		(16)		(30)		(186)										Russia / Ukraine conflict charges 3		—			—			—			—			—			(31)			(109)			(16)			(30)			(186)
Indemnification and other transactions related costs 4		—		—		—		12		12
Loss on early extinguishment of debt 4																				Loss on early extinguishment of debt 4		—			—			—			(8)			(8)			—			—			—			(8)			(8)
Indemnification and other transactions related costs 5																				Indemnification and other transactions related costs 5		—			—			—			(8)			(8)			—			—			—			4			4
Total	Total	$	(31)	$	(109)	$	(16)	$	(69)	$	(225)									Total		$	—		$	—		$	—		$	(77)		$	(77)		$	(31)		$	(109)		$	(16)		$	(146)		$	(302)

1.Includes costs associated with implementing the Company's Digital Acceleration program.

2.Includes costs associated with implementing the Company's 2020 Restructuring Program.

3.Asset related charges due to the Russia and Ukraine conflict. See Note 4 for additional information.

4.The Company redeemed outstanding long-term debt resulting in a loss on early extinguishment.

5.Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

Table of Contents


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Pursuant to General Instruction H(1)(a) and (b) for Form 10-Q "Omission of Information by Certain Wholly-Owned Subsidiaries," TDCC is filing this Form 10-Q with a reduced disclosure format.

~~Table of Contents~~

OUTLOOK

Looking ahead, Dow will continue to execute its near-term cost savings actions and advance its longer term strategic priorities as it manages through a macro environment that is expected to remain challenging in the ~~remainder~~second half of the year. The Company's actions outlined in the first quarter are on track to deliver $1 billion of cost savings this year ~~Dow's consistent~~ and ~~disciplined execution enhances its ability to navigate the impact of higher inflation on consumer demand and soft global economic activity.~~ Dow expects ~~the benefit of its operational and cost actions~~ to continue to ~~build as~~benefit from the solid financial position and focus on cash flow generation it ~~progresses through 2023. Dow will remain flexible, responding quickly as conditions evolve~~has demonstrated since spin. In addition, Dow's disciplined and ~~expects oil and gas spreads~~balanced capital allocation priorities continue to ~~further~~ support ~~its strategic cost-advantaged positions. The underlying long-term growth fundamentals in Dow's market verticals remain intact as Dow advances both~~ its decarbonize and grow and transform the waste ~~strategies~~investments to ~~raise~~deliver long-term value creation for its ~~underlying earnings profile by $3 billion across the economic cycle.~~stakeholders.

OVERVIEW

The following is a summary of the results for the three months ended ~~March 31,~~June 30, 2023:

•The Company reported net sales in the ~~first~~second quarter of 2023 of ~~$11.9~~$11.4 billion, down 2227 percent from ~~$15.3~~$15.7 billion in the ~~first~~second quarter of 2022, with decreases across all operating segments and geographic regions; Packaging & Specialty Plastics (down 2028 percent), Industrial Intermediates & Infrastructure (down 2527 percent) and Performance Materials & Coatings (down 2527 percent).

•Local price decreased 1018 percent compared with the ~~first~~second quarter of 2022 with decreases across all operating segments; Packaging & Specialty Plastics (down 1121 percent), Industrial Intermediates & Infrastructure (down 615 percent) and Performance Materials & Coatings (down 1216 percent). Local price decreased in all geographic regions compared with the ~~first~~second quarter of 2022.

•Volume decreased 118 percent compared with the ~~first~~second quarter of 2022. Volume decreased in all operating segments; Packaging & Specialty Plastics (down 87 percent) Industrial Intermediates & Infrastructure (down 1711 percent) and Performance Materials & Coatings (down 1110 percent). Volume decreased in all geographic regions, except Latin America ~~which was flat.~~(up 3 percent).

•Currency had an unfavorable impact of 1 percent on net sales compared with the ~~first~~second quarter of 2022, driven by EMEAI (down 31 percent) and Asia Pacific (down 32 percent).

•Restructuring and asset related charges - net were $541 million in the first quarter of 2023, reflecting actions related to the 2023 Restructuring Program, which was approved by the Dow Inc. Board on January 25, 2023. The restructuring charges consisted of severance and related benefit costs of $344 million and asset write-downs and write-offs of $197 million.

•Equity in losses of nonconsolidated affiliates was ~~$48~~$57 million in the ~~first~~second quarter of 2023, compared with equity in earnings of nonconsolidated affiliates of ~~$174~~$195 million in the ~~first~~second quarter of 2022, primarily due to ~~lower integrated polyethylene margins and lower demand~~declines at ~~the Company's principal joint ventures.~~Sadara.

•Net income ~~(loss)~~ available for Dow Inc. and TDCC common stockholder(s) was ~~a loss of $93~~$485 million and ~~$100~~$487 million, respectively, in the ~~first~~second quarter of 2023, compared with ~~income of $1,569~~$1,661 million and ~~$1,561~~$1,667 million in the ~~first~~second quarter of 2022. Earnings ~~(loss)~~ per share for Dow Inc. was ~~a loss per share of $0.13~~$0.68 in the ~~first~~second quarter of 2023, compared with ~~earnings~~$2.26 per share ~~of $2.11~~ in the ~~first~~second quarter of 2022. ~~These decreases reflect lower local prices and reduced operating rates to match market dynamics.~~

•Cash provided by operating activities - continuing operations was ~~$531~~$1,347 million in the ~~first~~second quarter of 2023, down ~~$1.1 billion~~$509 million compared with the same period last year. ~~Compared with the fourth quarter of 2022, cash~~Cash provided by operating activities - continuing operations ~~decreased $1.5 billion.~~was up $816 million compared with the first quarter of 2023.

•Dow Inc. repurchased ~~$125~~$250 million of the Company's common stock in the ~~first~~second quarter of 2023.

•On ~~February 9,~~April 13, 2023, Dow Inc. announced that its Board of Directors ("Board") declared a dividend of $0.70 per share, which was paid on ~~March 10, 2023, to shareholders of record as of February 28, 2023.~~

~~In addition, the following events occurred subsequent to the first quarter of 2023:~~

•~~On April 13, 2023, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on~~ June 9, 2023, to shareholders of record as of May 31, 2023.

3433

Table of Contents

•On May 11, 2023, Dow Inc. announced Seadrift, Texas, as the location of its small modular nuclear reactor project as part of the joint development agreement with X-Energy Reactor Company, LLC.

•On June 15, 2023, Fitch Ratings affirmed TDCC’s BBB+ long-term credit rating and announced a short-term credit rating upgrade to F1 from F2, and also revised its long-term outlook to stable from positive.

•On June 19, 2023, Dow Inc. released its INtersections Progress Report, demonstrating how the Company's continued focus and actions align to its ambition and goal to deliver value growth; best-in-class performance; and innovative, sustainable solutions to address global challenges.

In addition, the following events occurred subsequent to the second quarter of 2023:

•On July 14, 2023, an incident occurred that included an explosion and subsequent fire at Dow's Louisiana Operations Glycol-2 unit in Plaquemine, Louisiana. There were no injuries reported from the incident. The incident was limited to the Glycol-2 unit with minimal disruption to other site operations at this time. The Company has initiated a root cause investigation and is developing a plan to restore operations. The Company's preliminary estimated impact on pretax earnings from the incident is $100 million.

RESULTS OF OPERATIONS

Net Sales

The following tables summarize net sales and sales variances by operating segment and geographic region from the prior year:


Summary of Sales Results	Summary of Sales Results	Three Months Ended				Summary of Sales Results	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net sales	Net sales	$	11,851	$	15,264			Net sales	$	11,420	$	15,664	$	23,271	$	30,928


Sales Variances by Operating Segment and Geographic Region	Sales Variances by Operating Segment and Geographic Region																								Sales Variances by Operating Segment and Geographic Region		Three Months Ended Jun 30, 2023									Six Months Ended Jun 30, 2023
		Three Months Ended Mar 31, 2023
		Local Price & Product Mix		Currency			Volume			Total
Sales Variances by Operating Segment and Geographic Region													Sales Variances by Operating Segment and Geographic Region		Local Price & Product Mix			Currency			Volume			Total			Local Price & Product Mix			Currency		Volume		Total
	Percentage change from prior year																																			Local Price & Product Mix		Currency		Volume		Total		Percentage change from prior year	Local Price & Product Mix	Currency	Volume	Total
Packaging & Specialty Plastics	Packaging & Specialty Plastics		Packaging & Specialty Plastics		(21)		%	—		%	(7)		%	(28)		%	(16)		%	(1)		%	(7)		%	(24)		%
Industrial Intermediates & Infrastructure	Industrial Intermediates & Infrastructure	(6)		(2)			(17)			(25)															Industrial Intermediates & Infrastructure		(15)			(1)		(11)		(27)		(11)		(1)		(14)		(26)
Performance Materials & Coatings	Performance Materials & Coatings	(12)		(2)			(11)			(25)															Performance Materials & Coatings		(16)			(1)		(10)		(27)		(14)		(2)		(10)		(26)
Total	Total	(10)	%	(1)		%	(11)		%	(22)		%													Total		(18)		%	(1)	%	(8)	%	(27)	%	(14)	%	(1)	%	(10)	%	(25)	%
Total, excluding the Hydrocarbons & Energy business	Total, excluding the Hydrocarbons & Energy business	(9)	%	(2)		%	(11)		%	(22)		%													Total, excluding the Hydrocarbons & Energy business		(17)		%	—	%	(7)	%	(24)	%	(13)	%	(1)	%	(9)	%	(23)	%
U.S. & Canada	U.S. & Canada	(11)	%	—		%	(9)		%	(20)		%													U.S. & Canada		(17)		%	—	%	(8)	%	(25)	%	(14)	%	—	%	(9)	%	(23)	%
EMEAI	EMEAI	(8)		(3)			(15)			(26)															EMEAI		(19)			(1)		(14)		(34)		(14)		(2)		(14)		(30)
Asia Pacific	Asia Pacific	(11)		(3)			(12)			(26)															Asia Pacific		(17)			(2)		(4)		(23)		(14)		(2)		(8)		(24)
Latin America	Latin America	(11)		—			—			(11)															Latin America		(20)			—		3		(17)		(15)		—		1		(14)
Total	Total	(10)	%	(1)		%	(11)		%	(22)		%													Total		(18)		%	(1)	%	(8)	%	(27)	%	(14)	%	(1)	%	(10)	%	(25)	%

Net sales in the ~~first~~second quarter of 2023 were ~~$11.9~~$11.4 billion, down 2227 percent from ~~$15.3~~$15.7 billion in the ~~first~~second quarter of 2022, with local price down 1018 percent, volume down 118 percent and an unfavorable currency impact of 1 percent. Net sales decreased in all operating segments and geographic regions, primarily driven by lower demand and prices due to slower economic ~~growth.~~activity. Local price decreased in Packaging & Specialty Plastics (down 1121 percent), Industrial Intermediates & Infrastructure (down 615 percent), and Performance Materials & Coatings (down 1216 percent), driven by lower demand as well as global energy and feedstock costs. Volume decreased in all operating segments and geographic regions except Latin America (up 3 percent). Volume decreased in Packaging & Specialty Plastics (down 7 percent), Industrial Intermediates & Infrastructure (down 11 percent) and Performance Materials & Coatings (down 10 percent). Currency unfavorably impacted net sales by 1 percent, driven by Asia

Table of Contents

Pacific (down 2 percent) and EMEAI (down 1 percent). Excluding the Hydrocarbons & Energy business, net sales decreased 24 percent.

Net sales for the first six months of 2023 were $23.3 billion, down 25 percent from $30.9 billion in the same period last year, with local price down 14 percent, volume down 10 percent and an unfavorable currency impact of 1 percent. Net sales decreased in all operating segments and geographic regions, primarily driven by lower demand and prices due to slower economic activity. Local price decreased in Packaging & Specialty Plastics (down 16 percent), Industrial Intermediates & Infrastructure (down 11 percent), and Performance Materials & Coatings (down 14 percent), driven by industry supply additions. Volume decreased in all operating segments and geographic regions except Latin America ~~which was flat.~~(up 1 percent). Volume decreased in Packaging & Specialty Plastics (down 87 percent), Industrial Intermediates & Infrastructure (down 1714 percent) and Performance Materials & Coatings (down 1110 percent). Currency unfavorably impacted net sales by 1 percent, driven by EMEAI (down 32 percent) and Asia Pacific (down 32 percent). Excluding the Hydrocarbons & Energy business, net sales decreased 2223 percent.

Cost of Sales

Cost of sales ("COS") was ~~$10.6~~$9.9 billion in the second quarter of 2023, compared with $12.9 billion in the second quarter of 2022. For the first six months of 2023, COS was $20.5 billion, compared with $25.3 billion in the first six months of 2022. COS in the second quarter and for the first six months of 2023 ~~down from $12.4 billion in the first quarter of 2022,~~decreased primarily due to lower raw material costs on lower ~~volume.~~volume and lower global energy and feedstock costs. COS as a percentage of net sales was ~~89.7~~86.5 percent in the ~~first~~second quarter of 2023 ~~compared with 81.2~~(82.3 percent in the ~~first~~second quarter of ~~2022.~~2022) and 88.1 percent for the first six months of 2023 (81.8 percent for the first six months of 2022).

Research and Development Expenses

Research and development ("R&D") expenses totaled ~~$214~~$205 million in the ~~first~~second quarter of 2023, compared with ~~$218~~$217 million in the second quarter of 2022. R&D expenses for the first six months of 2023 were $419 million, compared with $435 million in the first ~~quarter~~six months of 2022. R&D expenses in the second quarter and for the first six months of 2023 decreased due to lower performance-based compensation costs, which more than offset increases in labor costs and fringe benefit expenses tied to stock market changes.

Selling, General and Administrative Expenses

Selling, general and administrative ("SG&A") expenses totaled ~~$428~~$408 million in the ~~first~~second quarter of 2023, compared with ~~$498~~$435 million in the second quarter of 2022. For the first six months of 2023, SG&A expenses were $836 million, compared with $933 million in the first ~~quarter~~six months of 2022. SG&A expenses ~~decreased~~ in the second quarter and for the first ~~quarter~~six months of 2023 decreased due to lower

~~Table of Contents~~

performance-based compensation costs and bad debt reserve write-offs, which more than ~~offsetting~~offset increases in labor costs ~~as well as~~and fringe benefit expenses tied to stock market changes.

Amortization of Intangibles

Amortization of intangibles was $81 million in the ~~first~~second quarter of 2023, compared with ~~$88~~$85 million in the second quarter of 2022. In the first six months of 2023, amortization of intangibles was $162 million, compared with $173 million in the first ~~quarter~~six months of 2022.

Restructuring and Asset Related Charges - Net

2023 Restructuring Program

On January 25, 2023, the Dow Inc. Board approved restructuring actions to achieve the Company's structural cost improvement initiatives in response to the continued economic impact from the global recessionary environment and to enhance its agility and long-term competitiveness across the economic cycle. As a result of these actions, in the first quarter of 2023 the Company recorded pretax restructuring charges of $541 million, consisting of severance and related benefit costs of $344 million and asset write-downs and write-offs of $197 million. Restructuring charges by segment were as follows: $1 million in Packaging & Specialty Plastics, $40 million in Industrial Intermediates & Infrastructure, $49 million in Performance Materials & Coatings and $451 million in Corporate. In the second quarter of 2023, the Company recorded additional pretax restructuring charges related to asset write-downs and write-offs of $8 million (related to Industrial Intermediates & Infrastructure). These actions are expected to be substantially complete by the end of 2024.

Table of Contents

Asset Related Charges

Equity in Earnings (Losses) of Nonconsolidated Affiliates

The Company's share of equity in losses of nonconsolidated affiliates was ~~$48~~$57 million in the ~~first~~second quarter of 2023, compared with equity in earnings of nonconsolidated affiliates of ~~$174~~$195 million in the second quarter of 2022, primarily due to equity losses at Sadara and the Kuwait joint ventures as the result of lower local prices and demand and planned maintenance turnaround activity. The Company's share of equity in losses of nonconsolidated affiliates was $105 million for the first ~~quarter~~six months of 2023, compared with equity in earnings of nonconsolidated affiliates of $369 million for the first six months of 2022, primarily due to lower integrated polyethylene margins and equity losses at Sadara and the Kuwait joint ventures as the result of lower local prices and demand ~~at the Company's principal joint ventures. Dividends~~and planned maintenance turnaround activity. Cash dividends from nonconsolidated affiliates were ~~$53~~$162 million in the first ~~three~~six months of 2023, compared with ~~$548~~$658 million in the first ~~three~~six months of 2022.

Sundry Income (Expense) – Net

For the three months ended ~~March 31,~~June 30, 2023, Sundry income (expense) - net was income of ~~$79~~$31 million and ~~$69~~$29 million for Dow Inc. and TDCC, respectively, compared with income of ~~$148~~$75 million and ~~$136~~$78 million, respectively, for the three months ended ~~March 31,~~June 30, 2022. The ~~first~~second quarter of 2023 and 2022 included non-operating pension and postretirement benefit plan credits and gains on the sales of assets and investments. These were partially offset by foreign currency exchange losses. ~~In addition,~~

For the six months ended June 30, 2023, Sundry income (expense) - net was income of $110 million and $98 million for Dow Inc. and TDCC, respectively, compared with income of $223 million and $214 million, respectively, for the six months ended June 30, 2022. The first six months of 2023 and 2022 included ~~a $9 million gain associated with agreements entered into with DuPont de Nemours, Inc. ("DuPont")~~non-operating pension and ~~Corteva, Inc. ("Corteva") as part~~postretirement benefit plan credits and gains on the sales of ~~the separation~~assets and ~~distribution (related to Corporate).~~investments. These were partially offset by foreign currency exchange losses.

Interest Expense and Amortization of Debt Discount

Interest expense and amortization of debt discount was ~~$185~~$172 million in the ~~first~~second quarter of 2023, compared with ~~$167~~$165 million in the second quarter of 2022. Interest expense and amortization of debt discount was $357 million in the first ~~quarter~~six months of 2023, compared with $332 million in the first six months of 2022. The increase in interest expense is primarily due to higher interest rates in 2023.

Provision ~~(Credit)~~ for Income Taxes

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level. The Company reported a ~~credit~~provision for income taxes of ~~$47~~$210 million in the ~~first~~second quarter of 2023, resulting in an effective tax rate of ~~39.2~~29.5 percent for Dow Inc. and TDCC, compared with a provision of $488 million in the second quarter of 2022, resulting in an effective tax rate of 22.5 percent and ~~37.0~~22.4 percent for Dow Inc. and TDCC, respectively. For the first six months of 2023, the Company reported a provision for income taxes of $163 million, resulting in an effective tax rate of 27.6 percent and 27.8 percent for Dow Inc. and TDCC, respectively, compared with a provision of ~~$503~~$991 million infor the first ~~quarter~~six months of 2022, resulting in an effective tax rate of ~~24.5 percent and 24.6~~23.5 percent.

The ~~credit~~provision for income taxes in the second quarter and first six months of 2023 was primarily ~~due to negative pretax income and benefits related to deferred tax assets in a foreign jurisdiction, partially offset~~impacted by ~~a remeasurement of uncertain tax positions. These factors in conjunction with~~the geographic mix of earnings, which resulted in a higher tax rate ~~for the first quarter of 2023~~ compared with the ~~first quarter of~~same periods in 2022.

~~Table of Contents~~

Net Income ~~(Loss)~~ Available for Common Stockholder(s)

Dow Inc.

Net income ~~(loss)~~ available for Dow Inc. common stockholders was ~~a loss of $93~~$485 million, or ~~$0.13~~$0.68 per share, in the second quarter of 2023, compared with $1,661 million, or $2.26 per share, in the second quarter of 2022. Net income available for Dow Inc. common stockholders was $392 million, or $0.54 per share, in the first ~~quarter~~six months of 2023, compared with ~~income of $1,569~~$3,230 million, or ~~$2.11~~$4.37 per share, in the first ~~quarter~~six months of 2022. See Note 6 to the Consolidated Financial Statements for details on Dow Inc.'s earnings ~~(loss)~~ per share calculations.

Table of Contents

TDCC

Net income ~~(loss)~~ available for the TDCC common stockholder was ~~a loss of $100~~$487 million in the ~~first~~second quarter of 2023, compared with $1,667 million in the second quarter of 2022. Net income available for the TDCC common stockholder was $387 millionin the first six months of ~~$1,561~~2023, compared with $3,228 million in the first ~~quarter~~six months of 2022. TDCC's common shares are owned solely by Dow Inc.

SEGMENT RESULTS

For further discussion of the Company's segments, see Part I, Item 1. Business of the combined Dow Inc. and TDCC Annual Report on Form 10-K for the fiscal year ended December 31, 2022 ("2022 10-K"), filed with the SEC on February 1, 2023.

PACKAGING & SPECIALTY PLASTICS


Packaging & Specialty Plastics	Packaging & Specialty Plastics	Three Months Ended				Packaging & Specialty Plastics	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net sales	Net sales	$	6,114	$	7,627			Net sales	$	5,940	$	8,233	$	12,054	$	15,860
Operating EBIT	Operating EBIT	$	642	$	1,234			Operating EBIT	$	918	$	1,436	$	1,560	$	2,670
Equity earnings	Equity earnings	$	21	$	110			Equity earnings	$	19	$	138	$	40	$	248


~~Packaging & Specialty Plastics~~	~~Three Months Ended~~
~~Percentage change from prior year~~	~~Mar 31, 2023~~
~~Change in Net Sales from Prior Period due to:~~
~~Local price & product mix~~	~~(11)~~	%
~~Currency~~	~~(1)~~
~~Volume~~	~~(8)~~
~~Total~~	~~(20)~~	%


Packaging & Specialty Plastics	Three Months Ended		Six Months Ended
Percentage change from prior year	Jun 30, 2023		Jun 30, 2023
Change in Net Sales from Prior Period due to:
Local price & product mix	(21)	%	(16)	%
Currency	—		(1)
Volume	(7)		(7)
Total	(28)	%	(24)	%

Packaging & Specialty Plastics net sales were ~~$6,114~~$5,940 million in the ~~first~~second quarter of 2023, down 2028 percent from net sales of ~~$7,627~~$8,233 million in the ~~first~~second quarter of 2022, with local price down 1121 percent, volume down 87 percent and ~~an unfavorable~~ currency ~~impact of 1 percent.~~flat. Local price decreased in both businesses and across all geographic regions. Local price, primarily in EMEAI and the U.S. & Canada, ~~and EMEAI,~~ decreased in Hydrocarbons & Energy as prices for co-products are generally correlated to Brent crude oil prices, which, on average, decreased 1530 percent compared with the ~~first~~second quarter of 2022. Local price decreased in Packaging and Specialty Plastics in all geographic regions, driven by lower polyethylene ~~prices, which were partially offset by gains in functional polymers.~~prices. Volume decreased in Hydrocarbons & Energy, primarily in EMEAI, driven by lower sales of olefins and ~~aromatics sales primarily in EMEAI.~~aromatics. Volume decreased in Packaging and Specialty Plastics primarily due to lower demand in all geographic regions except for Latin America.

Operating EBIT was ~~$642~~$918 million in the ~~first~~second quarter of 2023, down ~~$592~~$518 million from Operating EBIT of ~~$1,234~~$1,436 million in the second quarter of 2022. Operating EBIT decreased primarily due to lower selling prices, reduced demand, and lower equity earnings, which were partially offset by lower raw material, energy and feedstock costs.

Packaging & Specialty Plastics net sales were $12,054 million in the first six months of 2023, down 24 percent from net sales of $15,860 million in the first six months of 2022, with local price down 16 percent, volume down 7 percent and an unfavorable currency impact of 1 percent. Local price decreased in both businesses and across all geographic regions. Local price, primarily in EMEAI and the U.S. & Canada, decreased in Hydrocarbons & Energy

Table of Contents

as prices for co-products are generally correlated to Brent crude oil prices, which, on average, decreased 23 percent compared with the first six months of 2022. Local price decreased in Packaging and Specialty Plastics in all geographic regions driven by lower polyethylene prices. Volume decreased in Hydrocarbons & Energy, driven by lower sales primarily in EMEAI. Volume decreased in Packaging and Specialty Plastics across all other geographic regions, except for Latin America.

Operating EBIT was $1,560 million in the first six months of 2023, down $1,110 million from Operating EBIT of $2,670 million in the first six months of 2022. Operating EBIT decreased primarily due to lower selling prices, reduced demand and lower equity earnings, which were partially offset by lower raw material, energy and feedstock costs.

INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE


Industrial Intermediates & Infrastructure	Three Months Ended				Six Months Ended
In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net sales	$	3,177	$	4,370	$	6,555	$	8,894
Operating EBIT	$	(35)	$	426	$	88	$	1,087
Equity earnings (losses)	$	(83)	$	57	$	(156)	$	119


Industrial Intermediates & Infrastructure	Three Months Ended		Six Months Ended
Percentage change from prior year	Jun 30, 2023		Jun 30, 2023
Change in Net Sales from Prior Period due to:
Local price & product mix	(15)	%	(11)	%
Currency	(1)		(1)
Volume	(11)		(14)
Total	(27)	%	(26)	%

Industrial Intermediates & Infrastructure net sales were $3,177 million in the second quarter of 2023, down 27 percent from $4,370 million in the second quarter of 2022, with local price down 15 percent, volume down 11 percent and an unfavorable currency impact of 1 percent. Local price and volume decreased in both businesses and across all geographic regions. Volume decreased in Polyurethanes & Construction Chemicals, driven by lower demand for consumer durables, building and construction, and industrial applications. Volume decreased in Industrial Solutions, driven by lower demand for coatings and industrial applications. The unfavorable currency impact was driven by EMEAI and Asia Pacific.

Operating EBIT was a loss of $35 million in the second quarter of 2023, down $461 million from Operating EBIT of $426 million in the second quarter of 2022. Operating EBIT decreased primarily due to lower selling prices and demand, and lower equity earnings ~~which were partially offset by lower raw materials~~at the Sadara and ~~energy costs driven by lower volume.~~

~~Table of Contents~~

~~INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE~~

Industrial Intermediates & Infrastructure Three Months Ended
In millions Mar 31, 2023 Mar 31, 2022
Net sales $ 3,378 $ 4,524
Operating EBIT $ 123 $ 661
Equity earnings (losses) $ (73) $ 62


~~Industrial Intermediates & Infrastructure~~	~~Three Months Ended~~
~~Percentage change from prior year~~	~~Mar 31, 2023~~
~~Change in Net Sales from Prior Period due to:~~
~~Local price & product mix~~	~~(6)~~	%
~~Currency~~	~~(2)~~
~~Volume~~	~~(17)~~
~~Total~~	~~(25)~~	%

EQUATE joint ventures.

Industrial Intermediates & Infrastructure net sales were ~~$3,378~~$6,555 million in the first ~~quarter~~six months of 2023, down 2526 percent from ~~$4,524~~net sales of $8,894 million in the first ~~quarter~~six months of 2022, with local price down 611 percent, volume down 1714 percent and an unfavorable currency impact of 21 percent. Local price decreased in both businesses and across all geographic regions. Currency had an unfavorable impact on sales in both ~~businesses, driven by EMEAI and Asia Pacific.~~businesses. Volume ~~decreased in both businesses and across all geographic regions. Volume decreased~~ in Polyurethanes & Construction Chemicals ~~driven by~~decreased in all geographic regions, primarily due to lower demand, particularly for ~~building & construction,~~ consumer durables, building and construction, and industrial applications. Volume ~~decreased~~ in Industrial Solutions decreased in all geographic regions, driven by lower demand for coatings and industrial applications. The unfavorable currency impact was driven by EMEAI and Asia Pacific.

Operating EBIT was ~~$123~~$88 million in the first ~~quarter~~six months of 2023, down ~~$538~~$999 million from Operating EBIT of ~~$661~~$1,087 million in the first ~~quarter~~six months of 2022. Operating EBIT decreased primarily due to lower selling prices and demand, ~~margin compression due to rising energy costs particularly in EMEAI~~ and lower equity earnings at the ~~EQUATE~~Sadara and ~~Sadara~~EQUATE joint ventures.

Table of Contents

PERFORMANCE MATERIALS & COATINGS


Performance Materials & Coatings	Performance Materials & Coatings	Three Months Ended				Performance Materials & Coatings	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net sales	Net sales	$	2,276	$	3,049			Net sales	$	2,197	$	3,003	$	4,473	$	6,052
Operating EBIT	Operating EBIT	$	35	$	595			Operating EBIT	$	66	$	561	$	101	$	1,156
Equity earnings	Equity earnings	$	3	$	3			Equity earnings	$	6	$	2	$	9	$	5


Performance Materials & Coatings	Three Months Ended		Six Months Ended
Percentage change from prior year	Jun 30, 2023		Jun 30, 2023
Change in Net Sales from Prior Period due to:
Local price & product mix	(16)	%	(14)	%
Currency	(1)		(2)
Volume	(10)		(10)
Total	(27)	%	(26)	%


~~Performance Materials & Coatings~~	~~Three Months Ended~~
~~Percentage change from prior year~~	~~Mar 31, 2023~~
~~Change in Net Sales from Prior Period due to:~~
~~Local price & product mix~~	~~(12)~~	%
~~Currency~~	~~(2)~~
~~Volume~~	~~(11)~~
~~Total~~	~~(25)~~	%

~~Table of Contents~~

Performance Materials & Coatings net sales were ~~$2,276~~$2,197 million in the ~~first~~second quarter of 2023, down 2527 percent from net sales of ~~$3,049~~$3,003 million in the ~~first~~second quarter of 2022, with local price down 1216 percent, volume down 1110 percent and an unfavorable currency impact of 1 percent. Local price decreased in both businesses and across all geographic regions. Consumer Solutions local price decreased primarily due to unfavorable supply and demand dynamics in upstream siloxanes. Local price decreased in Coatings & Performance Monomers primarily in acrylic monomers and architectural coatings and was driven by lower raw material prices. Volume decreased in Consumer Solutions in the U.S. & Canada, EMEAI and Latin America, partially offset by an increase in Asia Pacific. Volume decreased in Coatings & Performance Monomers in the U.S. & Canada, EMEAI and Asia Pacific, and was partially offset by an increase in Latin America. The unfavorable currency impact was driven by Asia Pacific and EMEAI.

Operating EBIT was $66 million in the second quarter of 2023, down $495 million from Operating EBIT of $561 million in the second quarter of 2022. Operating EBIT decreased primarily due to price decreases and lower demand in both businesses.

Performance Materials & Coatings net sales were $4,473 million in the first six months of 2023, down 26 percent from net sales of $6,052 million in the first six months of 2022, with local price down 14 percent, volume down 10 percent and an unfavorable currency impact of 2 percent. Local price decreased in both businesses and across all geographic regions. Consumer Solutions local price decreased primarily due to competitive pricing pressure from supply additions in China in upstream siloxanes. Local price decreased in Coatings & Performance Monomers primarily due to lower raw material prices ~~and unfavorable supply and demand dynamics~~ in acrylic monomers and architectural coatings. Volume decreased in Consumer Solutions in ~~EMEAI,~~ the U.S. & Canada, EMEAI and Latin America, partially offset by an increase in Asia Pacific. Volume decreased in Coatings & Performance Monomers in all ~~regions, driven by lower demand for architectural coatings.~~geographic regions. The unfavorable currency impact was driven by ~~EMEAI~~Asia Pacific and ~~Asia Pacific.~~EMEAI.

Operating EBIT was ~~$35~~$101 million in the first ~~quarter~~six months of 2023, down ~~$560~~$1,055 million from Operating EBIT of ~~$595~~$1,156 million in the first ~~quarter~~six months of 2022. Operating EBIT decreased primarily due to price decreases ~~in Consumer Solutions~~ and lower demand in both businesses.

CORPORATE


Corporate	Corporate	Three Months Ended				Corporate	Three Months Ended				Six Months Ended
In millions	In millions	Mar 31, 2023		Mar 31, 2022				In millions	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Net sales	Net sales	$	83	$	64			Net sales	$	106	$	58	$	189	$	122
Operating EBIT	Operating EBIT	$	(92)	$	(71)			Operating EBIT	$	(64)	$	(48)	$	(156)	$	(119)
Equity earnings (losses)	Equity earnings (losses)	$	1	$	(1)			Equity earnings (losses)	$	1	$	(2)	$	2	$	(3)

Table of Contents

Net sales for Corporate, which primarily relate to the Company's insurance operations, were ~~$83~~$106 million in the ~~first~~second quarter of 2023, an increase from net sales of ~~$64~~$58 million in the second quarter of 2022. Net sales were $189 million in the first ~~quarter~~six months of 2023, an increase from net sales of $122 million in the first six months of 2022.

Operating EBIT was a loss of ~~$92~~$64 million in the ~~first~~second quarter of 2023, compared with a loss of ~~$71~~$48 million in the ~~first~~second quarter of 2022. Operating EBIT ~~decreased~~was a loss of $156 million in the first six months of 2023, compared with a loss of $119 million in the first six months of 2022. Operating EBIT declined primarily due to increased environmental costs.

CHANGES IN FINANCIAL CONDITION

The Company had cash and cash equivalents of ~~$3,319~~$2,924 million at ~~March 31,~~June 30, 2023 and $3,886 million at December 31, 2022, of which ~~$1,610~~$1,568 million at ~~March 31,~~June 30, 2023 and $1,789 million at December 31, 2022 was held by subsidiaries in foreign countries, including U.S. territories. For each of its foreign subsidiaries, Dow makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

Cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. Dow has the ability to repatriate additional funds to the United States, which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. At ~~March 31,~~June 30, 2023, management believed that sufficient liquidity was available in the United States. The Company has and expects to continue repatriating certain funds from its non‑U.S. subsidiaries that are not needed to finance local operations; however, these particular repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.

~~Table of Contents~~

The Company's cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table:


Cash Flow Summary	Cash Flow Summary	Dow Inc.				TDCC				Cash Flow Summary	Dow Inc.				TDCC
		Three Months Ended				Three Months Ended					Six Months Ended				Six Months Ended
		Mar 31, 2023		Mar 31, 2022		Mar 31, 2023		Mar 31, 2022			Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
In millions
Cash provided by (used for):	Cash provided by (used for):										Cash provided by (used for):
Operating activities - continuing operations	Operating activities - continuing operations	$	531	$	1,612	$	534	$	1,611	Operating activities - continuing operations	$	1,878	$	3,468	$	1,896	$	3,493
Operating activities - discontinued operations	Operating activities - discontinued operations	4		(9)		—		—		Operating activities - discontinued operations	4		(11)		—		—
Operating activities	Operating activities	535		1,603		534		1,611		Operating activities	1,882		3,457		1,896		3,493
Investing activities	Investing activities	(150)		(367)		(150)		(367)		Investing activities	(834)		(763)		(834)		(763)
Financing activities	Financing activities	(854)		(1,017)		(853)		(1,025)		Financing activities	(1,907)		(3,096)		(1,921)		(3,132)

Cash Flows from Operating Activities

Cash provided by operating activities from continuing operations in the first ~~three~~six months of 2023 was primarily driven by the Company's cash earnings, which were partially offset by cash used for working capital requirements and performance-based compensation payments. Cash provided by operating activities from continuing operations in the first ~~three~~six months of 2022 was primarily driven by the Company's cash earnings and dividends from equity method investments, which were partially offset by cash used for working capital requirements and performance-based compensation payments.


Net Working Capital	Net Working Capital	Dow Inc.				TDCC				Net Working Capital	Dow Inc.				TDCC
		Mar 31, 2023		Dec 31, 2022		Mar 31, 2023		Dec 31, 2022			Jun 30, 2023		Dec 31, 2022		Jun 30, 2023		Dec 31, 2022
In millions	In millions									In millions
Current assets	Current assets	$	19,356	$	20,477	$	19,330	$	20,511	Current assets	$	18,549	$	20,477	$	18,512	$	20,511
Current liabilities	Current liabilities	10,489		11,331		10,347		11,247		Current liabilities	9,649		11,331		9,502		11,247
Net working capital	Net working capital	$	8,867	$	9,146	$	8,983	$	9,264	Net working capital	$	8,900	$	9,146	$	9,010	$	9,264
Current ratio	Current ratio	1.85:1		1.81:1		1.87:1		1.82:1		Current ratio	1.92:1		1.81:1		1.95:1		1.82:1

Working Capital Metrics Three Months Ended
Mar 31, 2023 Mar 31, 2022
Days sales outstanding in trade receivables 43 42
Days sales in inventory 58 55
Days payables outstanding 59 60

Table of Contents


Working Capital Metrics	Three Months Ended
	Jun 30, 2023	Mar 31, 2023	Jun 30, 2022

Days sales outstanding in trade receivables	45	43	43
Days sales in inventory	61	58	56
Days payables outstanding	61	59	58

Cash provided by (used for) operating activities from discontinued operations in the first ~~three~~six months of 2023 and 2022 was related to cash payments and receipts Dow Inc. had with DuPont and Corteva that related to certain agreements and matters related to the separation from DowDuPont Inc. ("DowDuPont").

Cash Flows from Investing Activities

Cash used for investing activities in the first ~~three~~six months of 2023 and 2022 were primarily for capital expenditures and purchases of investments, which were partially offset by proceeds from sales and maturities of investments.

The Company's capital expenditures were ~~$440~~$1,001 million in the first ~~three~~six months of 2023, compared with ~~$315~~$772 million in the first ~~three~~six months of 2022. The Company expects full year capital spending in 2023 to be approximately $2.2 billion. The Company will adjust its spending through the year as economic conditions evolve.

Cash Flows from Financing Activities

Cash used for financing activities in the first ~~three~~six months of 2023 was primarily for debt related ~~activities, partially offset by proceeds from issuance of common stock.~~activities. In addition, Dow Inc. included cash outflows for dividends paid to stockholders and purchases of treasury stock. TDCC included cash outflows for dividends paid to Dow Inc. Cash used for financing activities in the first ~~three~~six months of 2022 ~~included~~was primarily for payments on long-term debt, ~~related activity,~~which was partially offset by

~~Table of Contents~~

~~collections related to securitization programs and~~ proceeds from issuance of common stock. In addition, Dow Inc. included cash outflows for dividends paid to stockholders and purchases of treasury stock. TDCC included cash outflows for dividends paid to Dow Inc.

Dow Inc. Non-GAAP Cash Flow Measures

Free Cash Flow

Dow defines Free Cash Flow as "Cash provided by operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by Dow from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represents the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

Operating EBITDA

Dow defines Operating EBITDA as earnings (i.e., "Income ~~(loss)~~ before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

Cash Flow Conversion (Operating EBITDA to Cash Flow from Operations)

Dow defines Cash Flow Conversion (Operating EBITDA to Cash Flow from Operations) as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

These financial measures are not recognized in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and should not be viewed as alternatives to GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, Dow's definitions may not be consistent with the methodologies used by other companies.


Reconciliation of Free Cash Flow	Reconciliation of Free Cash Flow	Three Months Ended						Reconciliation of Free Cash Flow	Six Months Ended
		Mar 31, 2023			Mar 31, 2022				Jun 30, 2023			Jun 30, 2022
In millions
Cash provided by operating activities - continuing operations (GAAP)	Cash provided by operating activities - continuing operations (GAAP)			$	531		$	1,612	Cash provided by operating activities - continuing operations (GAAP)		$	1,878		$	3,468
Capital expenditures	Capital expenditures	(440)			(315)			Capital expenditures	(1,001)			(772)
Free Cash Flow (non-GAAP)	Free Cash Flow (non-GAAP)	$	91		$	1,297		Free Cash Flow (non-GAAP)	$	877		$	2,696

Table of Contents


Reconciliation of Cash Flow Conversion (Operating EBITDA to Cash Flow from Operations)	Reconciliation of Cash Flow Conversion (Operating EBITDA to Cash Flow from Operations)	Three Months Ended						Reconciliation of Cash Flow Conversion (Operating EBITDA to Cash Flow from Operations)	Six Months Ended
		Mar 31, 2023			Mar 31, 2022				Jun 30, 2023			Jun 30, 2022
In millions
Net income (loss) (GAAP)				$	(73)		$	1,552
+ Provision (credit) for income taxes		(47)			503
Income (loss) before income taxes		$	(120)		$	2,055
Net income (GAAP)								Net income (GAAP)	$	428		$	3,233
+ Provision for income taxes								+ Provision for income taxes	163			991
Income before income taxes								Income before income taxes	$	591		$	4,224
- Interest income	- Interest income	76			28			- Interest income	142			64
+ Interest expense and amortization of debt discount	+ Interest expense and amortization of debt discount	185			167			+ Interest expense and amortization of debt discount	357			332
- Significant items ¹	- Significant items ¹	(719)			(225)			- Significant items ¹	(787)			(302)
Operating EBIT (non-GAAP)	Operating EBIT (non-GAAP)	$	708		$	2,419		Operating EBIT (non-GAAP)	$	1,593		$	4,794
+ Depreciation and amortization	+ Depreciation and amortization	648			752			+ Depreciation and amortization	1,297			1,436
Operating EBITDA (non-GAAP)	Operating EBITDA (non-GAAP)	$	1,356		$	3,171		Operating EBITDA (non-GAAP)	$	2,890		$	6,230
Cash provided by operating activities - continuing operations (GAAP)	Cash provided by operating activities - continuing operations (GAAP)	$	531		$	1,612		Cash provided by operating activities - continuing operations (GAAP)	$	1,878		$	3,468
Cash Flow Conversion (Operating EBITDA to cash flow from operations) (non-GAAP)	Cash Flow Conversion (Operating EBITDA to cash flow from operations) (non-GAAP)	39.2		%	50.8		%	Cash Flow Conversion (Operating EBITDA to cash flow from operations) (non-GAAP)	65.0		%	55.7		%

1.The ~~three~~six months ended ~~March 31,~~June 30, 2023 includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program, certain gains and losses associated with previously impaired equity investments, a loss associated with legacy agricultural products groundwater contamination matters and activity related to the separation from DowDuPont. The ~~three~~six months ended ~~March 31,~~June 30, 2022 includes costs associated with implementing the Company's Digital Acceleration program and 2020 Restructuring Program, asset related charges due to the Russia and Ukraine conflict, a loss on early extinguishment of debt and activity related to the separation from DowDuPont. See Note 16 to the Consolidated Financial Statements for additional information.

~~Table of Contents~~

Liquidity & Financial Flexibility

The Company’s primary source of incremental liquidity is cash flows from operating activities. The generation of cash from operations and the Company's ability to access capital markets is expected to meet the Company’s cash requirements for working capital, capital expenditures, debt maturities, contributions to pension plans, dividend distributions to stockholders, share repurchases and other needs. In addition to cash from operating activities, the Company’s current liquidity sources also include TDCC's U.S. and Euromarket commercial paper programs, committed and uncommitted credit facilities, committed accounts receivable facilities, a medium-term notes program, a U.S. retail note program (“InterNotes®”) and other debt markets.

The Company continues to maintain a strong financial position with all of its committed credit facilities undrawn and fully available at ~~March 31,~~June 30, 2023. Cash and committed and available forms of liquidity were ~~$13.2~~$12.8 billion at ~~March 31,~~June 30, 2023. The Company also has no substantive long-term debt maturities due until 2027. As a well-known seasoned issuer the Company may issue debt at any time as an additional source of liquidity. Additional details on sources of liquidity are as follows:

Commercial Paper

TDCC issues promissory notes under its U.S. and Euromarket commercial paper programs. TDCC had ~~$200 million of~~no commercial paper outstanding at ~~March 31,~~June 30, 2023. TDCC maintains access to the commercial paper market at competitive rates. Amounts outstanding under TDCC's commercial paper programs during the period may be greater, or less than, the amount reported at the end of the period. TDCC did not issue commercial paper subsequent to ~~March 31,~~June 30, 2023.

Committed Credit Facilities

The Company also has the ability to access liquidity through TDCC's committed and available credit facilities. At ~~March 31,~~June 30, 2023, TDCC had total committed and available credit facilities of $8.4 billion.

Uncommitted Credit Facilities

The Company has entered into various uncommitted bilateral credit arrangements as a potential source of excess liquidity. These lines can be used to support short-term liquidity needs and for general purposes, including letters of credit. The Company had no drawdowns outstanding at ~~March 31,~~June 30, 2023.

Table of Contents

Committed Accounts Receivable Facilities

In addition to the above committed credit facilities, the Company maintains a committed accounts receivable facility in the U.S. where eligible trade accounts receivable, up to $900 million, may be sold at any point in time. The Company also maintains a committed accounts receivable facility in Europe where eligible trade accounts receivable, up to €500 million, may be sold at any point in time. In the ~~first~~second quarter of 2023, the Company sold no receivables under the U.S. and Europe committed accounts receivable facilities ~~($250 million~~(the Company sold no receivables in the first ~~three~~ sixmonths of ~~2022)~~2023).

Company-Owned Life Insurance

The Company has investments in company-owned life insurance ("COLI") policies, which are recorded at their cash surrender value as of each balance sheet date. The Company has the ability to monetize its investment in its COLI policies as an additional source of liquidity. The Company had no outstanding monetization of its existing COLI policies' surrender value at ~~March 31,~~June 30, 2023.

~~Table of Contents~~

Debt

As the Company continues to maintain its strong balance sheet and financial flexibility, management is focused on net debt (a non-GAAP financial measure), as the Company believes this is the best representation of its financial leverage at this point in time. As shown in the following table, net debt is equal to total gross debt minus "Cash and cash equivalents" and "Marketable securities."


Total Debt	Total Debt	Dow Inc.						TDCC						Total Debt	Dow Inc.						TDCC
		Mar 31, 2023			Dec 31, 2022			Mar 31, 2023			Dec 31, 2022				Jun 30, 2023			Dec 31, 2022			Jun 30, 2023			Dec 31, 2022
In millions
Notes payable	Notes payable			$	278		$	362		$	278		$	362	Notes payable		$	102		$	362		$	102		$	362
Long-term debt due within one year	Long-term debt due within one year	247			362			247			362			Long-term debt due within one year	107			362			107			362
Long-term debt	Long-term debt	14,739			14,698			14,739			14,698			Long-term debt	14,735			14,698			14,735			14,698
Gross debt	Gross debt	$	15,264		$	15,422		$	15,264		$	15,422		Gross debt	$	14,944		$	15,422		$	14,944		$	15,422
- Cash and cash equivalents	- Cash and cash equivalents	3,319			3,886			3,319			3,886			- Cash and cash equivalents	2,924			3,886			2,924			3,886
- Marketable securities 1	- Marketable securities 1	619			939			619			939			- Marketable securities 1	716			939			716			939
Net debt	Net debt	$	11,326		$	10,597		$	11,326		$	10,597		Net debt	$	11,304		$	10,597		$	11,304		$	10,597
Total equity	Total equity	$	20,715		$	21,247		$	20,953		$	21,489		Total equity	$	20,509		$	21,247		$	20,736		$	21,489

Gross debt as a percent of total capitalization	Gross debt as a percent of total capitalization	42.4		%	42.1		%	42.1		%	41.8		%	Gross debt as a percent of total capitalization	42.2		%	42.1		%	41.9		%	41.8		%
Net debt as a percent of total capitalization	Net debt as a percent of total capitalization	35.3		%	33.3		%	35.1		%	33.0		%	Net debt as a percent of total capitalization	35.5		%	33.3		%	35.3		%	33.0		%

1.Included in "Other current assets" in the consolidated balance sheets.

The Company may at any time repurchase certain debt securities in the open market or in privately negotiated transactions subject to: the applicable terms under which any such debt securities were issued, certain internal approvals of the Company, and applicable laws and regulations of the relevant jurisdiction in which any such potential transactions might take place. This in no way obligates the Company to make any such repurchases nor should it be considered an offer to do so.

TDCC's public debt instruments and primary, private credit agreements contain, among other provisions, certain customary restrictive covenant and default provisions. TDCC's most significant debt covenant with regard to its financial position is the obligation to maintain the ratio of its consolidated indebtedness to consolidated capitalization at no greater than 0.70 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") equals or exceeds $500 million. The ratio of TDCC's consolidated indebtedness to consolidated capitalization as defined in the Revolving Credit Agreement was 0.40 to 1.00 at ~~March 31,~~June 30, 2023. Management believes TDCC was in compliance with all of its covenants and default provisions at ~~March 31,~~June 30, 2023. For information on TDCC's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2022 10-K. There were no material changes to the debt covenants and default provisions related to TDCC’s outstanding long-term debt and primary, private credit agreements in the first ~~three~~six months of 2023.

While taking into consideration the current economic environment, management expects that the Company will continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.

Table of Contents

Credit Ratings

At ~~March 31,~~June 30, 2023, TDCC's credit ratings were as follows:


Credit Ratings	Long-Term Rating	Short-Term Rating	Outlook
Fitch Ratings	BBB+	F2F1	~~Positive~~Stable
Moody’s Investors Service	Baa1	P-2	Stable
Standard & Poor’s	BBB	A-2	Positive

On June 15, 2023, Fitch Ratings affirmed TDCC’s BBB+ long-term credit rating and announced a short-term credit rating upgrade to F1 from F2, and also revised its long-term outlook to stable from positive. This decision was made as part of an annual review process and reflects the Company's supportive financial policies and strong operating performance.

~~Table of Contents~~

Dividends

Dow Inc.

Dow Inc. has paid dividends on a quarterly basis since the separation from DowDuPont and expects to continue to do so, subject to approval by the Dow Inc. Board. Dividends declared by the Board align to the Company's strategy announced in 2018 of returning approximately 45 percent of Operating Net Income to shareholders through dividends and total shareholder remuneration of approximately 65 percent, when including share repurchases, over the economic cycle. The Company defines Operating Net Income, a non-GAAP measure, as "Net income ~~(loss)~~ available for Dow Inc. common stockholders," excluding the impact of significant items. The following table summarizes dividends declared and paid to common stockholders of record in 2023:


Dow Inc. Dividends Declared and Paid
Declaration Date	Record Date	Payment Date	Amount (per share)
February 9, 2023	February 28, 2023	March 10, 2023	$	0.70
April 13, 2023	May 31, 2023	June 9, 2023	$	0.70

TDCC

TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders and share repurchases, as approved by the Dow Inc. Board, as well as certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. For the three months ended ~~March 31,~~June 30, 2023, TDCC declared and paid a dividend to Dow Inc. of ~~$620~~$758 million ($~~1,121~~1,378 million for the ~~three~~six months ended ~~March 31, 2022)~~June 30, 2023). At ~~March 31,~~June 30, 2023, TDCC's intercompany loan balance with Dow Inc. was insignificant.

Share Repurchase Program

On April 13, 2022, the Dow Inc. Board approved a share repurchase program authorizing up to $3 billion for the repurchase of the Company's common stock, with no expiration date. The Company repurchased ~~$125~~$250 million of its common stock in the ~~first~~second quarter of ~~2023.~~2023 ($375 million in the first six months of 2023). At ~~March 31,~~June 30, 2023, approximately ~~$1,925~~$1,675 million of the ~~new~~ share repurchase program authorization remained available for repurchases. As previously announced, the Company intends to repurchase shares to cover dilution over the cycle. The Company may from time to time expand its share repurchases beyond dilution, based on a number of factors including macroeconomic conditions, free cash flow generation, and the Dow share price. Any share repurchases, when coupled with the Company's dividends, are intended to implement the long-term strategy of targeting shareholder remuneration of approximately 65 percent over the economic cycle.

Pension Plans

The Company has both funded and unfunded defined benefit pension plans that cover employees in the United States and a number of other countries. The Company's funding policy is to contribute to funded plans when pension laws and/or economics either require or encourage funding. In the second quarter of 2023, the Company received a pension asset reversion of approximately $90 million for a portion of the excess funding of one of its plans in Europe. This plan asset reversion is included in "Other assets and liabilities, net" in the consolidated statements of cash flows. See Note 12 to the Consolidated Financial Statements and Note 19 to the Consolidated Financial Statements included in the 2022 10-K for additional information related to the Company's pension plans.

Table of Contents

Restructuring

The actions related to the 2023 Restructuring Program are expected to result in additional cash expenditures of ~~$333~~$273 million, primarily through 2024 and consist primarily of severance and related benefit costs. Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions, and costs associated with the Company's productivity and efficiency actions, are expected to result in additional cash expenditures of approximately ~~$425~~$340 million, primarily through the end of 2024. Restructuring implementation and efficiency costs totaled ~~$40~~$47 million in the ~~first~~second quarter of 2023.

The Company expects to incur additional costs in the future related to its restructuring activities, which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits related to its other optimization activities. These costs cannot be reasonably estimated at this time. See Note 4 to the Consolidated Financial Statements for additional information on the Company's restructuring activities.

~~Table of Contents~~

Contractual Obligations

Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest can be found in Notes 14, 15, 16 and 19 to the Consolidated Financial Statements included in the 2022 10-K. With the exception of the items noted below, there have been no material changes in the Company’s contractual obligations since December 31, 2022.


Contractual Obligations at Mar 31, 2023		Payments Due In
Contractual Obligations at Jun 30, 2023												Contractual Obligations at Jun 30, 2023	Payments Due In
In millions	In millions	2023		2024-2025		2026-2027		2028 and beyond		Total		In millions	2023		2024-2025		2026-2027		2028 and beyond		Total
Dow Inc.	Dow Inc.											Dow Inc.
Long-term debt obligations 1	Long-term debt obligations 1	$	222	$	523	$	1,306	$	13,212	$	15,263	Long-term debt obligations 1	$	59	$	518	$	1,327	$	13,206	$	15,110
Expected cash requirements for interest 2	Expected cash requirements for interest 2	$	518	$	1,350	$	1,300	$	8,664	$	11,832	Expected cash requirements for interest 2	$	343	$	1,353	$	1,301	$	8,673	$	11,670

Purchase obligations 3												Purchase obligations 3	$	1,641	$	4,092	$	2,336	$	3,905	$	11,974

1.Excludes unamortized debt discount and issuance costs of ~~$277~~$268 million. Includes finance lease obligations of ~~$787~~$749 million.

2.Cash requirements for interest on long-term debt was calculated using current interest rates at ~~March 31,~~June 30, 2023, and includes $6$1 million of various floating rate notes.

3.Includes outstanding purchase orders and other commitments greater than $1 million obtained through a survey conducted within the Company.

Fair Value Measurements

See Note 15 to the Consolidated Financial Statements for information concerning fair value measurements.

OTHER MATTERS

Critical Accounting Estimates

The preparation of financial statements and related disclosures in accordance with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements included in the 2022 10-K describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. The Company’s critical accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the 2022 10-K. Since December 31, 2022, there have been no material changes in the Company’s accounting policies that are impacted by judgments, assumptions and estimates.

Asbestos-Related Matters of Union Carbide Corporation

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos‑containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

Table of Contents

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants:


Asbestos-Related Claim Activity	Asbestos-Related Claim Activity	2023	2022	Asbestos-Related Claim Activity	2023	2022
Claims unresolved at Jan 1	Claims unresolved at Jan 1	6,873	8,747	Claims unresolved at Jan 1	6,873	8,747
Claims filed	Claims filed	940	1,214	Claims filed	1,911	2,388
Claims settled, dismissed or otherwise resolved	Claims settled, dismissed or otherwise resolved	(765)	(1,154)	Claims settled, dismissed or otherwise resolved	(1,622)	(2,275)
Claims unresolved at Mar 31		7,048	8,807
Claims unresolved at Jun 30				Claims unresolved at Jun 30	7,162	8,860
Claimants with claims against both Union Carbide and Amchem	Claimants with claims against both Union Carbide and Amchem	(1,479)	(2,072)	Claimants with claims against both Union Carbide and Amchem	(1,457)	(2,106)
Individual claimants at Mar 31		5,569	6,735
Individual claimants at Jun 30				Individual claimants at Jun 30	5,705	6,754

~~Table of Contents~~

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. ~~In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants.~~ For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 8 to the Consolidated Financial Statements; Part II, Item 1. Legal Proceedings; and Note 15 to the Consolidated Financial Statements included in the 2022 10-K.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See Note 14 to the Consolidated Financial Statements and Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2022, for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.


ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, Dow Inc. and The Dow Chemical Company (the "Companies") carried out an evaluation, under the supervision and with the participation of the Companies' Disclosure Committee and the Companies' management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Companies' disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Companies' disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in the Companies' internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the quarter ended ~~March 31,~~June 30, 2023, that have materially affected, or are reasonably likely to materially affect, the Companies' internal control over financial reporting.

Table of Contents


Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries PART II – OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS

Asbestos-Related Matters of Union Carbide Corporation

No material developments regarding this matter occurred in the first ~~three~~six months of 2023. For a current status of this matter, see Note 8 to the Consolidated Financial Statements.

Environmental Proceedings

In June 2023, INEMA, the Bahia state environmental agency notified Dow Brasil Indústria e Comércio de Produtos Químicos Ltda of its intention to impose penalties relating to Dow’s historic brine mining operations on Matarandiba Island, which INEMA alleges have contributed to environmental issues at the location. Discussions between Dow and the relevant government agencies are ongoing.


ITEM 1A. RISK FACTORS

Since December 31, 2022, there have been no material changes to the Company's Risk Factors.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The following table provides information regarding purchases of Dow Inc. common stock by the Company during the three months ended ~~March 31,~~June 30, 2023:

Issuer Purchases of Equity Securities Total number of shares purchased as part of the Company's publicly announced share repurchase program
Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program 1
(In millions)
Period Total number of shares purchased Average price paid per share
January 2023 — $ — — $ 2,050
February 2023 700,626 $ 57.09 700,626 $ 2,010
March 2023 1,484,259 $ 57.27 1,484,259 $ 1,925
First quarter 2023 2,184,885 $ 57.21 2,184,885 $ 1,925


Issuer Purchases of Equity Securities				Total number of shares purchased as part of the Company's publicly announced share repurchase program	Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program 1 (In millions)
Period	Total number of shares purchased	Average price paid per share
April 2023	—	$	—	—	$	1,925
May 2023	2,361,695	$	52.93	2,361,695	$	1,800
June 2023	2,459,526	$	50.82	2,459,526	$	1,675
Second quarter 2023	4,821,221	$	51.85	4,821,221	$	1,675

1.On April 13, 2022, the Dow Inc. Board approved a share repurchase program authorizing up to $3.0 billion for the repurchase of the Company's common stock, with no expiration date.


ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.


ITEM 5. OTHER INFORMATION

Not applicable.

Table of Contents


ITEM 6. EXHIBITS


			EXHIBIT NO.						DESCRIPTION
			4.3						Dow Inc. agrees to provide the SEC, on request, copies of all other such indentures and instruments that define the rights of holders of long-term debt of Dow Inc. and its consolidated subsidiaries, including The Dow Chemical Company, pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K.
			23 *						Ankura Consulting Group, LLC's Consent.
			31.1 *						Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			31.2 *						Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			32.1 *						Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
			32.2 *						Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
			101.INS						The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
			101.SCH						Inline XBRL Taxonomy Extension Schema Document.
			101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.
			101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.
			101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document.
			101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.
			104						Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

* Filed herewith


TRADEMARK LISTING

The following registered trademark of InspereX Holdings LLC appears in this report: InterNotes®

® ™ Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow, except as otherwise specified.

Table of Contents


Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DOW INC.

THE DOW CHEMICAL COMPANY

Date: ~~April~~July 26, 2023


/s/ RONALD C. EDMONDS
Ronald C. Edmonds Controller and Vice President of Controllers and Tax (Authorized Signatory and Principal Accounting Officer)


Fair Value of Financial Instruments	Mar 31, 2023								Dec 31, 2022
In millions	Cost		Gain		Loss		Fair Value		Cost		Gain		Loss		Fair Value
Cash equivalents:
Held-to-maturity securities 1	$	714	$	—	$	—	$	714	$	872	$	—	$	—	$	872
Money market funds	1,273		—		—		1,273		355		—		—		355
Total cash equivalents	$	1,987	$	—	$	—	$	1,987	$	1,227	$	—	$	—	$	1,227
Marketable securities 2	$	610	$	9	$	—	$	619	$	927	$	12	$	—	$	939
Other investments:
Debt securities:
Government debt 3	$	762	$	1	$	(122)	$	641	$	754	$	1	$	(133)	$	622
Corporate bonds	1,272		9		(134)		1,147		1,274		10		(159)		1,125
Total debt securities	$	2,034	$	10	$	(256)	$	1,788	$	2,028	$	11	$	(292)	$	1,747
Equity securities 4	5		13		—		18		5		5		—		10
Total other investments	$	2,039	$	23	$	(256)	$	1,806	$	2,033	$	16	$	(292)	$	1,757
Total cash equivalents, marketable securities and other investments	$	4,636	$	32	$	(256)	$	4,412	$	4,187	$	28	$	(292)	$	3,923
Long-term debt including debt due within one year 5	$	(14,986)	$	1,389	$	(642)	$	(14,239)	$	(15,060)	$	1,683	$	(498)	$	(13,875)
Derivatives relating to:
Interest rates 6	$	—	$	2	$	—	$	2	$	—	$	105	$	—	$	105
Foreign currency	—		66		(17)		49		—		115		(30)		85
Commodities 6	—		24		(30)		(6)		—		72		(61)		11
Total derivatives	$	—	$	92	$	(47)	$	45	$	—	$	292	$	(91)	$	201